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ABSTRACTS 
 
 Palladium-catalyzed and electrophilic cyclization reactions are among the most 
studied in synthetic organic chemistry.  However, these methodologies cannot always be 
generally applied to obtain good yields of a desired class of compounds.  Many factors, 
including the reaction conditions, the nature of the ligands, and the reactivity of the involved 
species determine the product and the yield.  This thesis describes several useful and novel 
palladium-catalyzed and electrophilic cyclization methodologies that have been optimized to 
obtain biologically and industrially useful carbocycles and heterocycles in good to excellent 
yields.  These methods are tolerant of a number of functional groups including, a halogen 
moiety, which is further subjected to palladium-catalyzed Sonogashira, Suzuki-Miyaura and 
CO insertion reactions. 
 Chapter 1 describes the synthesis of 3,4-disubstituted 2H-benzopyrans by the 
electrophilic cyclization of propargylic aryl ethers.  Emphasis has been placed on the 
iodocyclization reactions of these ethers using I2 and ICl as the electrophiles.  The 
regioselectivity of unsymmetrical propargylic aryl ethers has also been studied. 
 An innovative one step palladium-catalyzed aminocarbonylative cyclization is 
explored in Chapter 2.  Our method uses only one atmosphere of CO and requires no 
specialized equipment to obtain an important class of heterocycles called phthalimides, 
starting from commercially available primary amines and the corresponding ortho-
halobenzoates. 
 Arynes and organopalladium species both are very reactive and, therefore, their 
coupling reactions are limited in the literature, particularly due to the harsh conditions 
generally required to obtain arynes.  A novel palladium-catalyzed aryne annulation to obtain 
 ix
the important class of carbocycles known as 9-fluorenylidenes from ortho-halostyrenes and 
o-silylaryl triflates in the presence of CsF is described in Chapter 3.  The methodology has 
also been extended to the synthesis of 9,10-phenanthrenes from the corresponding ortho-halo 
allylic benzenes. 
 Obtaining a good sized library of important potential pharmacophores (e.g., indoles) 
is desirable in medicinal or pharmaceutical fields.  Chapter 4 describes the synthesis of 
highly substituted indoles in compliance with Lipinski rules.  The palladium-catalyzed 
reactions employed have achieved substitution at the 3-position of the indole moiety, which 
is difficult due to the electron-rich nature of the C-I bond.  The chemistry has been 
successfully transferred to a solid support and diversity has been achieved at the 5-position 
by various cleavage reactions.  
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GENERAL INTRODUCTION 
 The establishment of new or innovative synthetic methods for obtaining carbocycles 
and heterocycles is an area of active research in synthetic organic chemistry.  Although 
numerous electrophilic cyclization and palladium-catalyzed methods are known, they cannot 
be generally applied to all organic systems and, therefore, there is a constant need for 
improved methods for a particular class of compounds or for new molecules.  Introduction of 
a halogen moiety in a compound is highly desired as it provides a handle for further organic 
transformations.  Also, mild reaction conditions, which are tolerant of a variety of functional 
groups, are desirable since they can be subjected to further organic transformations.  Many 
times biologically active natural products are a good indicator of possible biologically active 
substrates.  Good methods for the synthesis of a library of small molecules are therefore 
desirable to both synthetic chemists and biologists.   
 An efficient method for the synthesis of 2H-benzopyrans is described in Chapter 1.  
Substituted propargylic aryl ethers on electrophilic cyclization by I2, ICl and PhSeBr give 
3,4-disubstituted 2H-benzopyrans in good to excellent yields.  The scope of the reaction has 
been studied using various substrates, and expanded by subsequent palladium-catalyzed 
Sonogashira and CO insertion reactions at the 3-position, using the iodine handle provided by 
this methodology. 
 The palladium-catalyzed aminocarbonylation is a highly desired reaction in organic 
chemistry, the major concern being the use of a high pressure of CO gas.  Chapter 2 
describes an efficient one step method of preparing 2-substituted isoindole-1,3-diones in 
good yields by the palladium-catalyzed aminocarbonylation of ortho-halobenzoates, which 
produces the corresponding ortho-amidocarboxylate, which further undergoes base-catalyzed 
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cyclization.  This methodology provides this important class of heterocycles in good to 
excellent yields using only one atmosphere of CO.  The methodology is tolerant of a halogen 
moiety, which is further subjected to palladium-catalyzed Sonogashira and Suzuki-Miyaura 
cross coupling reactions.     
 The use of arynes as reagents in synthetic organic chemistry has been somewhat 
limited, due to the harsh conditions needed to generate arynes and the often uncontrolled 
reactivity exhibited by these species.  Recently o-silylaryl triflates have been used to generate 
the corresponding arynes under very mild reaction conditions, which then undergo 
palladium-catalyzed annulation to give important classes of compounds.  An efficient route 
to a variety of 9-fluorenylidenes and 9,10-phenanthrenes is described in Chapter 3, which 
involves the reaction of ortho-halostyrenes and ortho-halo allylicbenzenes respectively, with 
o-silylaryl triflates in the presence of CsF. 
 Substituted indoles are prevalent in numerous natural products and are extremely 
important in medicinal chemistry.  Chapter 4 describes the parallel synthesis of a library of 
highly substituted indoles.  3-Iodoindoles have been prepared in excellent yields by coupling 
terminal acetylenes with N,N-dialkyl-o-iodoanilines in the presence of a Pd/Cu catalyst, 
followed by electrophilic cyclization of the resulting N,N-dialkyl-o-(1-alkynyl)anilines using 
I2 in CH2Cl2.  The iodine moiety at the 3-position is subjected to palladium-catalyzed 
Sonogashira and Suzuki-Miyaura reactions to obtain a library of highly substituted indoles.  
The coupling reactions have been successfully transferred to a solid-phase, facilitating the 
multistep synthesis and eliminating the cumbersome purification steps.  Various substituents 
have been introduced at the 5-position by employing different methods of cleavage. 
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Dissertation Organization 
 This dissertation is organized into four chapters.  Each of the first three chapters 
presented herein is written following the guidelines for a full paper in the Journal of Organic 
Chemistry, while the fourth chapter is written following the guidelines for a full paper in the 
Journal of Combinatorial Chemistry.  Each chapter is composed of the abstract, introduction, 
results and discussion, conclusion, experimental section, and references. 
 Chapter 1 discusses an efficient method for the synthesis of 3,4-disubstituted 2H-
benzopyrans in excellent yields by the electrophilic cyclization of substituted propargylic 
aryl ethers by I2, ICl and PhSeBr.     
 Chapter 2 presents the Pd-catalyzed, one-step synthesis of a variety of isoindole-1,3-
diones, commonly known as phthalimides, starting with the corresponding ortho-
halobenzoates and commercially available primary amines. 
 Chapter 3 describes an efficient Pd-catalyzed method for the synthesis of 9-
fluorenylidenes and 9,10-phenanthrenes by the reaction of the corresponding ortho-
halostyrenes and ortho-halo allylicbenzenes with o-silylaryl triflates and CsF.  
 Chapter 4 discusses the solution phase and the solid phase synthesis of a highly 
substituted indole library by the Pd-catalyzed coupling reactions of various 3-iodoindoles 
with terminal alkynes and aryl boronic acids. This chemistry has afforded a 42-member 
indole library compliant with Lipinski’s rules.  
 Finally, the 1H and 13C NMR spectra for all the new starting materials and products 
have been compiled in appendices A-D, following the general conclusions for this 
dissertation.  
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CHAPTER 1. SYNTHESIS OF 3,4-DISUBSTITUTED 2H-BENZOPYRANS 
THROUGH C-C BOND FORMATION VIA ELECTROPHILIC CYCLIZATION 
 
Based on a paper published in the Journal of Organic Chemistry35  
Shilpa A. Worlikar; Tanay Kesharwani; Tuanli Yao and Richard C. Larock* 
Department of Chemistry, Iowa State University, Ames, Iowa 50011 
 
Abstract 
 The electrophilic cyclization of substituted propargylic aryl ethers by I2, ICl and 
PhSeBr produces 3,4-disubstituted 2H-benzopyrans in excellent yields.  This methodology 
results in vinylic halides or selenides under mild reaction conditions, and tolerates a variety 
of functional groups, including methoxy, alcohol, aldehyde and nitro groups. 
 
Introduction 
2H-1-Benzopyrans, commonly known as 2H-benzopyrans or 2H-chromenes, are key 
structural units of a variety of biologically important compounds, many of which are 
pharmaceutically significant.  The 2H-benzopyran Daurichromenic acid is known to exhibit 
anti-HIV properties,1  while Coutareagenin possesses antidiabetic activity.2  Derivatives of 
3,4-diphenylchromans are known to have estrogenic activity.3  Numerous derivatives of 2H-
benzopyrans are useful for treatment of proliferative skin disorder and microbial infections4 
and show potent antifungal activity.5  Derivatives of 2H-benzopyrans, like 2,4-diphenyl-2H-
benzopyran and 2,2,4-triphenyl-2H-benzopyran, have been studied for their photochromic 
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behavior.6  Due to their biological and pharmaceutical importance, the isolation and synthesis 
of 2H-benzopyrans has received considerable attention in the literature. 
Substituted 2H-benzopyrans have been synthesized in our laboratories by the Pd(II)- 
catalyzed cyclization of allylic aryl ethers,7 while the palladium-catalyzed cross-coupling of 
4-trifluoromethanesulfonyloxy-2H-benzopyrans with arylboronic acids has also been 
reported in the literature.8  Syntheses of 2H-benzopyrans are also known using platinum and 
gold catalysis,9 Hg(II)-mediated cyclizations,10 Grignard reagents,11 and microwave 
irradiation.12   
A wide range of carbocycles and heterocycles have been constructed using the 
electrophilic cyclization of disubstituted alkynes13 and transition metal-catalyzed 
cyclizations.14,15  Many researchers, including those from our group, have utilized these 
cyclizations for the synthesis of benzofurans,16 furans,17 benzo[b]thiophenes,18 thiophenes,19 
naphthols,20 indoles,21 quinolines,22 isoquinolines,23 isocoumarins,24 isochromenes25 and 
polycyclic aromatics.26  Some methods are not compatible with functionality, while some 
require the use of costly metals as catalysts.  Recently Barluenga and co-workers reported the 
synthesis of 2H-benzopyrans by the cyclization of aryl propargylic ethers using costly 
IPy2BF4 and HBF4.27  They also reported two examples of the iodocyclization of propargylic 
ethers using I2 in water.  We report herein many examples and a general synthesis of 2H-
benzopyrans in good yields via electrophilic cyclization using the simple, inexpensive 
electrophiles I2, ICl, and PhSeBr in nitromethane. 
 
Results and Discussion 
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Our early studies mainly focused on the iodocyclization of substituted propargylic 
aryl ethers to give 3,4-disubstituted 2H-benzopyrans in excellent yields.  Phenyl 3-phenyl-2-
propynyl ether (1) was used as a model system for optimization of the reaction conditions 
using I2 or ICl (eq 1). 
 
O
Ph
I
I2 or ICl (1)
1 2
O
Ph  
 
Early in this work, conditions similar to our previous iodocyclization reactions were 
used.  For instance, the reaction was run with 0.25 mmol of 1, 2 equiv of NaHCO3 as the 
base, and 3 equiv of I2 in 5 ml of CH3CN at 25 oC to obtain a 61% isolated yield of the 
desired 3-iodo-4-phenyl-2H-benzopyran (2)27 (Table 1, entry 1).  Solvents, like CH2Cl2, 
CH3OH and DMF, resulted in lower yields (entries 2-4), but CH3NO2 gave a yield of 77% 
(entry 5).  No reaction was observed at 0 oC after 4 h (entry 6), while the reaction was messy 
and produced only a 42% yield at 40 oC (entry 7).  Reducing the amount of I2 to 2 equiv 
decreased the yield significantly to 53% (entry 8), while an increase in the number of 
equivalents of I2 caused a slight decrease in the yield to 69% (entry 9).  Reducing the reaction 
time to 12 h lowered the yield to 62% (entry 10), while there was no increase in yield when 
the reaction time was doubled to 48 h (entry 11).  The presence of the base proved to be 
important for the reaction as the yield was reduced to 58% without the base and only 70% 
with one equiv of the base (entries 12 and 13).  Several additional bases were examined in 
this reaction, but NaHCO3 was found to give the best yield (entries 14-16). 
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Table 1. Optimization of the Cyclization of Phenyl 3-Phenyl-2-propynyl Ether using I2 as the 
Electrophile (eq 1)a 
entry solvent I2 (equiv) base (equiv) time (h) % isolated yield 
1 CH3CN 3 NaHCO3 (2) 24 61 
2 CH2Cl2 3 NaHCO3 (2) 24 49 
3 CH3OH 3 NaHCO3 (2) 24 41 
4 DMF 3 NaHCO3 (2) 24 52 
5 CH3NO2 3 NaHCO3 (2) 24 77 
6 CH3NO2 3 NaHCO3 (2) 4 0b 
7 CH3NO2 3 NaHCO3 (2) 24 42c 
8 CH3NO2 2 NaHCO3 (2) 24 53 
9 CH3NO2 4 NaHCO3 (2) 24 69 
10 CH3NO2 3 NaHCO3 (2) 12 62 
11 CH3NO2 3 NaHCO3 (2) 48 76 
12 CH3NO2 3 - 24 58 
13 CH3NO2 3 NaHCO3 (1) 24 70 
14 CH3NO2 3 NaOMe (2) 24 69 
15 CH3NO2 3 Na2CO3 (2) 24 75 
16 CH3NO2 3 KOH (2) 24 - 
 
a Representative procedure:  phenyl 3-phenyl-2-propynyl ether (0.25 mmol), I2, a base and the solvent (5 mL) 
were placed in a 4 dram vial and stirred at 25 oC for the indicated time. b The reaction was run at 0 oC. c The 
reaction was run at 40 oC.   
 
In our previous cyclizations, ICl has proven to be a better electrophile for some 
substrates.  Therefore, with a view to obtaining better yields, the cyclization of phenyl 3-
phenyl-2-propynyl ether (1) was optimized using ICl as the electrophile, starting with our 
previously developed conditions.  Because of the importance of the solvent in such reactions, 
the reaction was carried out using CH2Cl2, diethyl ether, THF, hexane, CH3OH and CH3NO2 
at low temperatures (Table 2, entries 1-6).  The solvent CH3NO2  gave the best yield of 69%, 
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but the temperature had to be raised to -25 oC.  The reaction was run at -25 oC with the 
second best solvent for the reaction, namely CH2Cl2, to get a slightly lower yield of 65% 
(entry 7).  In all of these reactions, NaHCO3 was used as a base.  The yield increased to 96% 
when the reaction was carried out without NaHCO3 (entry 8).  Increasing the temperature to 0 
oC gave undetermined side products with the desired compound being formed in less than a 
5% yield (entry 9).  Decreasing or increasing the amount of ICl gave slightly lower yields  
 
Table 2. Optimization of the Cyclization of Phenyl 3-Phenyl-2-propynyl Ether using ICl as 
the Electrophile (eq 1)a 
Entry solvent ICl (equiv) temperature oC time (h) % yield 
1 CH2Cl2 1.5 -78 2 63b 
2 Ether 1.5 -78 2 51b 
3 THF 1.5 -78 2 58b 
4 Hexane 1.5 -78 2 49b 
5 CH3OH 1.5 -78 2 - b 
6 CH3NO2 1.5 -25 2 69b 
7 CH2Cl2 1.5 -25 2 65b 
8 CH3NO2 1.5 -25 0.5 96 
9 CH3NO2 1.5 0 0.5 <5 
10 CH3NO2 1.2 -25 2 71 
11 CH3NO2 2.0 -25 0.5 85 
 
a Representative procedure:  phenyl 3-phenyl-2-propynyl ether (0.25 mmol), ICl and the solvent (5 mL) were 
placed in a 4 dram vial and stirred at the indicated temperature for the indicated time. b NaHCO3 (0.5 mmol) 
was added.  
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(entries 10 and 11).  Thus, our optimized conditions using ICl are 0.25 mmol of 1, 1.5 equiv 
of ICl and 5 ml of CH3NO2 at -25 oC.  
After obtaining our best conditions using either I2 or ICl, we decided to study the 
scope of this reaction on various substrates.  Ethers 1, 4, 5 and 6 were obtained by standard 
Sonogashira chemistry28 using commercially available starting materials (Scheme 1).  Ethers 
9 and 10 were obtained by a two step approach, the first step being the synthesis of the 
substituted aryl propargylic ethers 7 and 8, followed by Sonogashira chemistry (Scheme 2).  
Ethers 11, 12 and 13 were synthesized by a Mitsunobu reaction (Scheme 3), while ethers 
14,29 15,30 16,30 17,27 18,31 19,31 20,31 2132 and 2233 (refer to Table 3) were previously 
reported in the literature. 
Scheme 1 
O I
R1 R2
+
2 mol % PdCl2(PPh3)2
Et3N
25 oC, 24 h
O
R1
R2
1.5 mol % CuI
3
1
4
5
6
74
75
85
79
H
Me
OMe
H
H
H
H
OMe
        % yield R1 R2
 
Scheme 2 
R1
R2
R3
OH
HC CCH2Br
1.1 equiv K2CO3
acetone
reflux
R1
R2
R3
O R1
R2
R3
O
Ph
2 mol % PdCl2(PPh3)2
1.5 mol % CuI
Et3N
1.5 equiv PhI
25 oC, 24 h
R1 R2 R3
H HCHO9
10 t-Bu t-BuH
%
45
50
R1 R2 R3
H HCHO7
8 t-Bu t-BuH
%
67
70
1.1 equiv
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Scheme 3 
R1
OH
+ R2
R1
O
R2
R1 R2 % yield
11 t-Bu Ph 61
12 H 1-cyclohexyl 50
1 equiv PPh3
1 equiv DEAD
benzene
25 oC
O
Ph
OH
+ Ph
1 equiv PPh3
1 equiv DEAD
benzene
25 oC
1350 %
OH
OH
 
 
Cyclizations were then carried out using our optimized conditions for I2 (conditions 
A) or ICl (conditions B).  3,4-Disubstituted 2H-benzopyrans were obtained in good yields 
using I2 or ICl when the substituent on the propargylic alkyne was either a simple phenyl or 
an alkenyl group (Table 3, entries 1, 2, 32 and 33).  An alkyl substituent on the alkyne 
terminus did not give the desired product with I2 or ICl as the electrophile, but worked with 
PhSeBr (entries 34-36).  However, an hydroxymethyl-substituted alkyne gave good yields 
with I2, as well as ICl (entries 37 and 38).  Simple phenyl propargyl ether (3) failed to give 
any of the desired product with I2 or ICl (entries 30 and 31).   
The introduction of substituents on the aryl groups has a considerable effect on the 
yield of the reaction.  Substituents were first introduced onto the aromatic ring attached to the 
alkyne.  Electron-donating groups, like Me and MeO in the para or ortho positions, gave 
good yields (entries 4-7, 10 and 11), while an electron-withdrawing group, like a NO2 group, 
gave relatively poor yields of 59% with I2 and 53% with ICl (entries 8 and 9).  Introducing 
substituents onto the aromatic ring attached to the oxygen moiety also has a pronounced 
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effect.  Electron-donating groups, like Me, t-Bu and MeO, on the phenyl ring para to the 
oxygen gave better yields with I2 as the electrophile (entries 12, 14 and 16) than those 
obtained using ICl (entries 13, 15 and 17).  Compound 30 was thus obtained in improved 
yields without the use of ion exchange resins as additives, as was reported by Barluenga.27  
The sterically-hindered ether 10 also gave good results (entries 23 and 24).   
Placing an electron-withdrawing chlorine in the position para to the oxygen gave 
somewhat lower yields (entries 18 and 19) of the desired isomer.  An aldehyde group in the 
position para to the oxygen gave a mixture of two inseparable regioisomers, the ratio of 
which depended on the electrophile used and the reaction temperature (entries 20 and21).  
The benzopyran isomer was favored when the reaction was carried out at -78 oC with CH2Cl2 
as the solvent and ICl as the electrophile (entry 22). 
 
Table 3. Synthesis of 3,4-Disubstituted 2H-Benzopyrans by Electrophilic Cyclization of 
Propargylic Aryl Ethers.a  
entry                             ether                       condition                   product(s)        % isolated 
                                                                                                                                    yield 
1 
O
 
1 A
O
Ph
I
 
2 77 
2  1 B  2 96 
3  1 C
O
Ph
SePh
 
23 95 
4 
O
Me
 
4 A
O
C6H4Me-p
I
 
24 88 
5  4 B  24 76 
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Table 3. Continued 
entry                             ether                       condition                   product(s)        % isolated 
                                                                                                                                    yield 
6 
O
OMe
 
5 A
O
C6H4OMe-p
I
 
25 89 
7  5 B  25 92 
8 
O
NO2
 
14 A
O
C6H4NO 2-p
I
 
26 59 
9  14 B  26 53 
10 O
MeO  
6 A
O
C6H4OMe-o
I
 
27 85 
11  6 B  27 88 
12 
OMe
 
15 A
O
Ph
IMe
 
28 79 
13  15 B  28 74 
14 
Ot -Bu
 
16 A
O
Ph
It -Bu
 
29 82 
15  16 B  29 77 
16 
OMeO
 
17 A
O
Ph
IMeO
 
30 92 
17  17 B  30 61 
18 
OCl
 
18 A
O
Ph
ICl
 
31 52 
19  18 B  31 75 
20 
OOHC
 
9 A
O
Ph
IOHC
 
       + 
32 76
b 
[2:1] 
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Table 3. Continued 
entry                             ether                       condition                   product(s)        % isolated 
                                                                                                                                    yield 
    
   
O
I
Ph
OHC
 
33  
21  9 B 32 + 33  
 
78b 
[1:11] 
22  9 D 32 + 33  
 
77b 
[6:1] 
23 O
t -Bu
t -Bu  
10 A
O
Ph
I
t -Bu
t -Bu
 
34 93 
24  10 B  34 77 
25 
O
t -Bu
 
11 A
O
Ph
I
t -Bu
 
35 72 
26  11 B  35 79 
27 
O
Cl
 
19 A
O
Ph
I
Cl
 
36 21 
    +   
    
O
Ph
I
Cl  
37 28 
28  19 B  36 27 
     +  
     37 42 
29 
O
MeO
 
20 B
O
Ph
I
MeO
 
         + 
38 
 
82b 
[2:3] 
    
         
O
Ph
I
OMe  
39  
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Table 3. Continued 
entry                             ether                       condition                   product(s)        % isolated 
                                                                                                                                    yield 
30 O
 
3 A   - 
31  3 B   - 
32 
O
 
12 A
O
I
 
40 74 
33  12 B  40 72 
34 O
Me
 
21 A   - 
35  21 B   - 
36  21 C
O
Me
SePh
 
41 79 
37 O
CH2OH
 
22 A
O
CH2OH
I
 
42 79 
38  22 B  42 72 
39 
O
Ph
 
13 A
O
Ph
I
 
43 61 
40  13 B  43 50 
 
a Representative procedure for conditions A:  ether (0.25 mmol), NaHCO3 (0.50 mmol), I2 (0.75 mmol) and 
CH3NO2 (5 mL) were placed in a 4 dram vial and stirred at 25 oC for 24 h. Conditions B:  ether (0.25 mmol), 
ICl (0.375 mmol) and CH3NO2 (5 mL) were placed in a 4 dram vial and stirred at -25 oC for 30 min.  Conditions 
C:  ether (0.25 mmol), PhSeBr (1.2 equiv) and CH2Cl2 (5 mL) were placed in a 4 dram vial and stirred at 25 oC 
for the indicated time.  Conditions D: CH2Cl2 was used as the solvent for conditions B at -78 oC. b The ratios 
were determined by 1H NMR spectroscopy.   
 
In order to study the regiochemistry of cyclization, the reaction was carried out with 
substituents meta to the oxygen moiety.  A sterically bulky t-Bu group in the meta position 
gave selectively one product 35 (entries 25 and 26).  A less bulky Cl in the meta position 
gave two regioisomers 36 and 37 (entries 27 and 28), while a MeO group gave a similar 
 
15
mixture of two inseparable regioisomers 38 and 39 (entry 29).  α-Naphthyl propargylic ether 
13 also gave the desired compound 43 in modest yields (entries 39 and 40). 
Phenyl 3-phenyl-2-propynyl ether (3) gave a 95% yield of the cyclized product 23 
when PhSeBr was used as the electrophile (entry 3).  Surprisingly, ether 21, which failed to 
give the desired product with I2 or ICl, gave a 79% yield of compound 41 with PhSeBr as the 
electrophile (entry 36).   
We believe that the mechanism of these cyclizations involves initial formation of an 
iodonium or selenonium intermediate by attack of the electrophile on the triple bond, 
followed by electrophilic attack on the electron cloud of the aromatic ring.  Loss of a  proton 
gives the 2H-benzopyran (Scheme 4).     
Scheme 4 
O
O
H
E
O
E
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E
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During our cyclization studies, ether 9 gave a mixture of two isomers, one being the 
expected benzopyran product and the other a possible five-membered ring dihydrofuran 
product.  This encouraged us to confirm the structure of our cyclized product 2 using X-ray 
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crystallography (see the Supporting Information), which indeed proved to be a 2H-
benzopyran. 
The iodo-(2H)-benzopyrans obtained by iodocyclization appear highly promising as 
intermediates for the preparation of more highly substituted benzopyrans.  Indeed 3-
iodobenzopyrans, like the ones prepared here, have recently been further elaborated by 
palladium-catalysed cross-coupling reactions.27  To further prove the utility of our 
methodology, we have carried out the palladium/copper-catalyzed reaction of our product 
2 with 5-ethynyl-2-fluorotoluene to obtain 44 in an 87 % yield.  Palladium catalysed CO 
insertion in our product 42 gave compound 45 in an overall 72 % yield (Scheme 5). 
Scheme 5 
O
I
O
F
Me
Me
F Et3N
O
O
O
O
CH2OH
I
+
1.5 mol % CuI
25 oC, 48 h
2 44
87%
42
5 mol % PdCl2(PPh3)2
CO (1 atm)
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Conclusions 
3,4-Disubstituted 2H-benzopyrans have been obtained from starting materials that are 
easy to synthesize.  The reaction conditions are mild and the products are easy to isolate in 
good yields.  The iodine moiety in the products provides a useful handle for further 
functionalization of the resulting heterocycles.  A polycyclic Sonogashira product 44 has 
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been obtained in a good yield.  Our methodology tolerates functional groups, including 
alcohol, aldehyde, methoxy and nitro groups. In addition to I2 and ICl, PhSeBr has also been 
used as the electrophile.  The structure of 3-iodo-4-phenyl-2H-benzopyran (2) has been 
confirmed by X-ray crystallography.  
 
Experimental Section  
 General.  The 1H and 13C NMR spectra were recorded at 300 and 75.5 MHz or 400 
and 100 MHz respectively.  Thin layer chromatography was performed using 60 mesh silica 
gel plates, and visualization was effected with short wavelength UV light (254 nm).  All 
melting points are uncorrected.  All high resolution mass spectra were recorded using EI at 
70 eV.  All reagents were used directly as obtained commercially unless otherwise noted.   
Preparation of starting materials. 
Substituted propargyl ether 7 was prepared according to a literature procedure.34 
General procedure for the palladium/copper-catalyzed reaction of phenyl 
propargyl ether with aryl halides.  To a solution of 2.5 mmol of the aryl halide in Et3N (15 
ml) was added PdCl2(PPh3)2 (2 mol %), which was then stirred for 5 min.  CuI (1.5 mol %) 
was then added and the flask was sealed and flushed with Ar.  The reaction was stirred for 20 
min.  A solution of 3.0 mmol of phenyl propargyl ether in 2 mL of Et3N was then added 
dropwise and the reaction mixture was allowed to stir at room temperature for the desired 
time.  After the reaction was over, the resulting solution was diluted with H2O (10 ml) and 
extracted with diethyl ether (3 x 15 mL).  The combined ether fractions were dried over 
anhydrous Na2SO4 and concentrated under vacuum to yield the crude product.  The crude 
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product was purified by flash chromatography on silica gel using ethyl acetate/hexanes as the 
eluent. 
3,5-Di-tert-butylphenyl propargyl ether (8).  To a solution of 2.06 g of 3,5-di-tert-
butylphenol (10.0 mmol) in dry acetone (50 ml) was added propargyl bromide (11.0 mmol) 
and anhydrous K2CO3 (11.0 mmol).  The resulting mixture was refluxed for 24 h.  The 
reaction mixture was diluted with H2O (20 ml) and extracted with diethyl ether (3 x 20 ml).  
The combined ether layers were dried over anhydrous Na2SO4 and concentrated under 
reduced pressure.  The residue was purified by flash chromatography on silica gel (7:1 
hexane/EtOAc) to afford 1.68 g of the indicated compound 7 (69% yield) as a yellow oil:  1H 
NMR (300 MHz, CDCl3) δ 1.30 (s, 18H), 2.42 (t, J = 2.5 Hz, 1H), 4.63 (d, J = 2.4 Hz, 2H), 
6.83 (d, J = 1.6 Hz, 2H), 7.05 (d, J = 1.5 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 31.5, 35.0, 
55.7, 75.4, 79.1, 109.4, 115.7, 152.2, 157.3; IR (neat, cm-1) 3298, 2939, 1588, 1424, 1285, 
1050; HRMS m/z 244.18311 (calcd C17H24O, 244.18272).  
General procedure for the palladium/copper-catalyzed reaction of terminal 
alkynes with iodobenzene.  To a solution of 4.5 mmol of iodobenzene in Et3N (15 ml), was 
added PdCl2(PPh3)2 (2 mol %), and CuI (1.5 mol %), and the mixture was stirred for 30 min 
under Ar.  A solution of 3.0 mmol of the terminal alkyne in 2 mL of Et3N was then added 
dropwise and the reaction mixture was allowed to stir at room temperature for the desired 
time.  After the reaction was over, the resulting solution was diluted with H2O (10 ml) and 
extracted with diethyl ether (3 x 15 mL).  The combined ether fractions were dried over 
anhydrous Na2SO4 and concentrated under vacuum to yield the crude product.  The crude 
product was purified by flash chromatography on silica gel using ethyl acetate/hexanes as the 
eluent. 
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General procedure for the triphenylphosphine/diethyl azodicarboxylate-
promoted formation of the substituted phenyl propargylic ethers.  To a solution of 1.31 g 
of PPh3 (5.0 mmol) in dry benzene (15 ml) was added the substituted propargylic alcohol 
(5.0 mmol) and the substituted phenol (5.0 mmol) under an inert atmosphere with stirring.  
Diethyl azodicarboxylate (0.87 g, 5.0 mmol) was then added slowly and the reaction mixture 
was stirred at r.t. for 18 to 36 h.  After the reaction was complete, the solvent was evaporated 
under reduced pressure and the crude product was purified by flash chromatography on silica 
gel using hexanes/ethyl acetate as the eluent.  
General procedure for iodocyclization.  To a solution of 0.25 mmol of the ether and 
3 mL of CH3NO2, 2.0 equiv of NaHCO3 and 3.0 equiv of I2 dissolved in 2 mL of CH3NO2 
was added gradually.  The reaction mixture was allowed to stir at room temperature for the 
desired time.  Alternatively, to a solution of 0.25 mmol of the ether and 3 mL of CH3NO2 at -
25 to -30 oC, 1.5 equiv of ICl dissolved in 2 mL of CH3NO2 was added gradually.  The 
reaction mixture was allowed to stir at -25 to -30 oC for the desired time.  The excess I2 or 
ICl was removed by washing with satd aq Na2S2O3.  The mixture was then extracted by 
diethyl ether (3 x 10 mL).  The combined ether layers were dried over anhydrous Na2SO4 and 
concentrated under vacuum to yield the crude product, which was purified by flash 
chromatography on silica gel using hexanes/ethyl acetate as the eluent. 
General procedure for the PhSeBr cyclizations.  To a solution of 0.25 mmol of the 
substituted phenyl propargylic ether and CH2Cl2 (3 mL), 0.375 mmol of PhSeBr dissolved in 
2 mL of CH2Cl2 was added dropwise.  The mixture was allowed to stir at room temperature 
for the desired time.  The reaction mixture was washed with 20 mL of water and extracted 
with diethyl ether (3 x 10 mL).  The combined ether layers were dried over anhydrous 
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Na2SO4 and concentrated under vacuum to yield the crude product, which was further 
purified by flash chromatography on silica gel using hexanes/ethyl acetate as the eluent. 
O
F
Me
44  
 3-(4-Fluoro-3-methylphenylethynyl)-4-phenyl-2H-benzopyran (44).  To a solution 
of 0.17 g of 3-iodo-4-phenyl-2H-benzopyran (2) (0.5 mmol) in Et3N (5 ml), was added 
PdCl2(PPh3)2 (2 mol %) and CuI (1.5 mol %), and the mixture was stirred for 30 min under 
Ar.  0.6 Mmol of 5-ethynyl-2-fluorotoluene dissolved in 1 mL of Et3N was then added 
dropwise and the reaction mixture was allowed to stir at room temperature for 24 h.  The 
reaction was monitored by TLC and an additional 0.4 mmol of the 5-ethynyl-2-fluorotoluene 
dissolved in 1 mL of Et3N was added slowly under an inert atmosphere and the reaction 
mixture was further allowed to stir at room temperature for another 24 h.  After the reaction 
was over, the resulting solution was diluted with H2O (5 ml) and extracted with diethyl ether 
(3 x 10 mL).  The combined ether fractions were dried over anhydrous Na2SO4 and 
concentrated under vacuum to yield the crude product, which was purified by flash 
chromatography on silica gel using hexanes/ethyl acetate as the eluent to obtain the desired 
compound 44 in an 87% yield as a pale yellow solid: mp 79-80 oC; 1H NMR (300 MHz, 
CDCl3) δ 2.18 (d, J = 1.6 Hz, 3H), 4.88 (s, 2H), 6.81-6.93 (m, 4H), 6.97-7.05 (m, 2H), 7.10-
7.21 (m, 1H), 7.39-7.45 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 14.6 (d, J = 3.4 Hz), 68.0, 
86.7 (d, J = 1.9 Hz), 95.1 (d, J = 0.8 Hz), 112.4, 115.3 (d, J = 9.4 Hz), 116.4, 118.9 (d, J = 
3.8 Hz), 121.8, 124.3, 125.3 (d, J = 18.2 Hz), 126.8, 128.2 (d, J = 10.2 Hz), 129.8, 130.2, 
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130.8 (d, J = 8.4 Hz), 134.7 (d, J = 5.7 Hz), 136.6, 140.8, 154.6, 160.1, 162.6; IR (neat, cm-1) 
3047, 2919, 2192, 1480, 1224, 1106; HRMS m/z 340.12694 (calcd C24H17FO, 340.12634). 
O
O
O
45  
1,4-Dihydro-2,5-dioxacyclopenta[a]naphthalen-3-one (45).  To a solution of 0.14 g 
of 4-hydroxymethyl-3-iodo-2H-benzopyran (42) (0.5 mmol) in DMF (5 ml) was added 
PdCl2(PPh3)2 (5 mol %) and K2CO3 (2 equiv), and the mixture was stirred for 6 h under an 
atmosphere of CO at 60 oC.  The reaction was monitored by TLC and, after completion of the 
reaction, the resulting solution was cooled to room temperature, diluted with ether (15 ml), 
and washed with brine (15 ml). The aqueous layer was extracted with diethyl ether (3 x 15 
mL).  The combined ether fractions were dried over anhydrous Na2SO4 and concentrated 
under vacuum to yield the crude product, which was purified by flash chromatography on 
silica gel using hexanes/ethyl acetate as the eluent to obtain the desired compound 45 in an 
72% yield as a brown solid: mp 151-152 oC; 1H NMR (400 MHz, CDCl3) 5.13-5.15 (m, 4H), 
6.92-6.99 (m, 2H), 7.07 (dd, J = 7.5, 1.5 Hz, 1H), 7.34 (dt, J = 8.2, 0.8 Hz, 1H); 13C NMR 
(100 MHz, CDCl3) δ 63.3, 68.8, 116.4, 117.2, 118.3, 122.0, 124.2, 133.8, 154.1, 154.8, 
170.7; IR (neat, cm-1) 2361, 1744, 1666, 1449, 1336, 1181, 1052; HRMS m/z 188.04776 
(calcd C11H8O3, 188.04743). 
Characterization data: 
O
Me
4  
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Phenyl 3-p-tolylprop-2-yn-1-yl ether (4).  This compound was obtained as a white 
solid: mp 71-72 oC; 1H NMR (300 MHz, CDCl3) δ 2.30 (s, 3H), 4.86 (s, 2H), 6.94-7.08 (m, 
5H), 7.18-7.33 (m, 4H); 13C NMR (75 MHz, CDCl3) δ 21.7, 56.9, 83.5, 87.5, 115.2, 119.5, 
121.6, 129.3, 129.7, 132.0, 139.0, 158.1; IR (neat, cm-1) 3032, 2914, 1598, 1490, 1214, 1029; 
HRMS m/z 222.10477 (calcd C16H14O, 222.10447). 
O
OMe
5  
3-(4-Methoxyphenyl)prop-2-yn-1-yl phenyl ether (5).  This compound was 
obtained as a light brown solid: mp 61-62 oC; 1H NMR (300 MHz, CDCl3) δ 3.77 (s, 3H), 
4.88 (s, 2H), 6.81 (d, J = 8.8 Hz, 2H), 6.95-7.03 (m, 3H), 7.27-7.38 (m, 4H); 13C NMR (75 
MHz, CDCl3) δ 55.4, 56.8, 82.7, 87.2, 114.0, 114.5, 115.1, 121.5, 129.6, 133.5, 158.0, 160.0; 
IR (neat, cm-1) 3042, 2919, 1598, 1506, 1239, 1024; HRMS m/z 238.09979 (calcd C16H14O2, 
238.09938). 
O
6
MeO
 
3-(2-Methoxyphenyl)prop-2-yn-1-yl phenyl ether (6).  This compound was 
obtained as a yellow oil: 1H NMR (300 MHz, CDCl3) δ 3.77 (s, 3H), 4.90 (s, 2H), 6.77-6.86 
(m, 2H), 6.95 (t, J = 7.3 Hz, 1H), 7.02 (d, J = 7.8 Hz, 2H), 7.20-7.30 (m, 3H), 7.36 (dd, J = 
7.6, 1.6 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 55.7, 56.9, 83.6, 88.1, 110.6, 111.4, 115.1, 
120.4, 121.3, 129.4, 130.2, 133.8, 157.9, 160.2; IR (neat, cm-1) 3057, 3032, 2934, 2243, 
1603, 1270, 1024; HRMS m/z 238.09968 (calcd C16H14O2, 238.09938). 
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OOHC
9  
 4-(3-Phenylprop-2-yn-1-yloxy)benzaldehyde (9).  This compound was obtained as 
a brown solid: mp 86-87 oC; 1H NMR (300 MHz, CDCl3) δ 5.00 (s, 2H), 7.14 (d, J = 8.8 Hz, 
2H), 7.25-7.32 (m, 3H), 7.41-7.44 (m, 2H), 7.87 (d, J = 8.8 Hz, 2H), 9.90 (s, 1H); 13C NMR 
(75 MHz, CDCl3) δ 57.0, 82.9, 88.1, 115.4, 122.0, 128.5, 129.1, 130.6, 132.0, 132.1, 162.8, 
191.0; IR (neat, cm-1) 3078, 2827, 1690, 1598, 1250, 1009; HRMS m/z 236.08409 (calcd 
C16H12O2, 236.08373). 
O
10
t-Bu
t-Bu  
 3,5-Di-tert-butylphenyl 3-phenylprop-2-yn-1-y1 ether (10).  This compound was 
obtained as a light yellow solid: mp 54-55 oC; 1H NMR (300 MHz, CDCl3) δ 1.32 (s, 18H), 
4.91 (s, 2H), 6.91 (d, J = 1.6 Hz, 2H), 7.06 (t, J = 1.5 Hz, 1H), 7.26-7.31 (m, 3H), 7.41-7.45 
(m, 2H); 13C NMR (75 MHz, CDCl3) δ 31.7, 35.2, 56.8, 84.5, 87.2, 109.6, 115.8, 122.6, 
128.5, 128.8, 132.0, 152.4, 157.6; IR (neat, cm-1) 3081, 2963, 1591, 1362, 1297, 1051; 
HRMS m/z 320.21446 (calcd C23H28O, 320.21402). 
t-Bu
O
11  
 3-tert-Butylphenyl 3-phenylprop-2-yn-1-y1 ether (11).  This compound was 
obtained as a yellow oil: 1H NMR (300 MHz, CDCl3) δ 1.30 (s, 9H), 4.86 (s, 2H), 6.83 (dd, J 
= 8.0, 2.3 Hz, 1H), 6.96-7.02 (m, 1H), 7.08 (t, J = 1.9 Hz, 1H), 7.19-7.25 (m, 4H), 7.39-7.42 
 
24
(m, 2H); 13C NMR (75 MHz, CDCl3) δ 31.4, 34.8, 56.6, 84.3, 87.2, 111.2, 113.1, 118.6, 
122.4, 128.4, 128.7, 129.1, 131.9, 153.0, 157.7; IR (neat, cm-1) 3067, 2955, 2868, 1588, 
1485, 1270, 1029; HRMS m/z 264.15187 (calcd C19H20O, 264.15142). 
O
12  
 3-(Cyclohex-1-enyl)prop-2-yn-1-yl phenyl ether (12).  This compound was 
obtained as a dark brown oil: 1H NMR (300 MHz, CDCl3) δ 1.53-1.62 (m, 4H), 2.04-2.10 
(m, 4H), 4.77 (s, 2H), 6.10-6.13 (m, 1H), 6.93-6.98 (m, 2H), 7.24-7.30 (m, 2H), 7.40-7.70 
(m, 1H); 13C NMR (75 MHz, CDCl3) δ 21.5, 22.3, 25.7, 29.0, 56.7, 81.3, 89.1, 115.0, 120.0, 
121.3, 129.5, 136.1, 157.9; IR (neat, cm-1) 3032, 2919, 2217, 1593, 1485, 1219; HRMS m/z 
212.12047 (calcd C15H16O, 212.12012). 
O
Ph
13  
 1-Naphthyl 3-phenylprop-2-yn-1-yl ether (13).  This compound was obtained as a 
light brown solid: mp 50-51 oC; 1H NMR (300 MHz, CDCl3) δ 5.08 (s, 2H), 6.99 (d, J = 7.4 
Hz, 1H), 7.26-7.49 (m, 9H), 7.77-7.80 (m, 1H), 8.30-8.33 (m, 1H); 13C NMR (75 MHz, 
CDCl3) δ 57.2, 84.2, 87.5, 105.9, 121.2, 122.4, 122.6, 125.6, 125.9, 126.0, 126.7, 127.7, 
128.5, 128.9, 132.0, 134.8, 153.8; IR (neat, cm-1) 3057, 2914, 1577, 1398, 1229, 1091; 
HRMS m/z 258.10497 (calcd C19H14O, 258.10447). 
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O
Ph
I
2  
 3-Iodo-4-phenyl-2H-benzopyran (2). This compound was obtained as a pale yellow 
solid: mp 99-100 oC; 1H NMR (300 MHz, CDCl3) δ 5.06 (s, 2H), 6.61 (dd, J = 7.7, 1.6 Hz, 
1H), 6.76 (dt, J = 7.7, 1.1 Hz, 1H), 6.85 (dd, J = 8.0, 1.0 Hz, 1H), 7.14 (dd, J = 7.9, 1.6 Hz, 
1H), 7.18-7.22 (m, 2H), 7.39-7.46 (m, 3H); 13C NMR (75 MHz, CDCl3) δ 75.1, 91.2, 116.1, 
121.7, 124.2, 126.5, 128.3, 128.7, 129.5, 129.7, 140.0, 142.0, 153.3; IR (neat, cm-1) 3062, 
2904, 1475, 1219, 1029, 994; HRMS m/z 333.98600 (calcd C15H11IO, 333.98547). 
 
Figure 1. X-ray structure of compound 2 
O
C6H4Me-p
I
24  
 3-Iodo-4-(4-methylphenyl)-2H-benzopyran (24). This compound was obtained as a 
pale brown solid: mp 68-69 oC; 1H NMR (300 MHz, CDCl3) δ 2.23 (s, 3H), 4.87 (s, 2H), 
6.46 (dd, J = 7.7, 1.6 Hz, 1H), 6.58 (t, J = 7.5 Hz, 1H), 6.66 (d, J = 8.0 Hz, 1H), 6.89-6.98 
(m, 3H), 7.07 (d, J = 8.3 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ 21.6, 75.2, 91.1, 116.1, 
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121.7, 124.4, 126.6, 129.4, 129.5, 129.7, 137.1, 138.1, 142.0, 153.5; IR (neat, cm-1) 3032, 
2914, 2842, 1475, 1219, 999; HRMS m/z 348.00051 (calcd C16H13IO, 348.00112). 
O
C6H4OMe-p
I
25  
 3-Iodo-4-(4-methoxyphenyl)-2H-benzopyran (25). This compound was obtained as 
a pale brown solid: mp 110-111 oC; 1H NMR (300 MHz, CDCl3) δ 3.85 (s, 3H), 5.05 (s, 2H), 
6.66 (dd, J = 7.7, 1.2 Hz, 1H), 6.77 (t, J = 7.4 Hz, 1H), 6.84 (d, J = 8.0 Hz, 1H), 6.96 (d, J = 
8.6 Hz, 2H), 7.11-7.17 (m, 3H); 13C NMR (75 MHz, CDCl3) δ 55.5, 75.2, 91.4, 114.1, 116.1, 
121.7, 124.6, 126.6, 129.7, 130.8, 132.3, 141.7, 153.5, 159.5; IR (neat, cm-1) 2955, 2918, 
2833, 1505, 1244, 1171, 1037; HRMS m/z 363.99640 (calcd C16H13IO2, 363.99603). 
O
C6H4NO2-p
I
26  
 3-Iodo-4-(4-nitrophenyl)-2H-benzopyran (26). This compound was obtained as a 
yellow solid: mp 140-142 oC (decomp.); 1H NMR (300 MHz, CDCl3) δ 5.07 (s, 2H), 6.50 
(dd, J = 7.7, 1.4 Hz, 1H), 6.79 (dt, J = 7.8, 0.9 Hz, 1H), 6.88 (dd, J = 8.2, 0.9 Hz, 1H), 7.19 
(dt, J = 8.0, 1.4 Hz, 1H), 7.41 (dd, J = 6.9, 1.9 Hz, 2H), 8.32 (dd, J = 6.9, 1.8 Hz, 2H); 13C 
NMR (75 MHz, CDCl3) δ 75.0, 91.8, 116.5, 122.0, 123.4, 124.1, 125.9, 130.4, 130.8, 140.4, 
146.6, 147.8, 153.2; IR (neat, cm-1) 3093, 2837, 1926, 1593, 1516, 1337, 1219; HRMS m/z 
378.97119 (calcd C15H10INO3, 378.97055). 
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O
C6H4OMe-o
I
27  
 3-Iodo-4-(2-methoxyphenyl)-2H-benzopyran (27). This compound was obtained as 
a light brown solid: mp 111-113 oC; 1H NMR (300 MHz, CDCl3) δ 3.75 (s, 3H), 5.01-5.13 
(m, 2H), 6.57 (dd, J = 7.8, 1.5 Hz, 1H), 6.74 (dt, J = 7.6, 1.1 Hz, 1H), 6.83 (dd, J = 7.1, 1.0 
Hz, 1H), 6.96-7.14 (m, 4H), 7.37-7.42 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 55.9, 74.9, 
92.7, 111.6, 116.0, 121.0, 121.7, 123.8, 126.1, 129.0, 129.5, 130.0, 131.0, 139.5, 153.2, 
156.9; IR (neat, cm-1) 2955, 2918, 1505, 1244, 1171, 1037; HRMS m/z 363.99644 (calcd 
C16H13IO2, 363.99603). 
O
Ph
IMe
28  
 3-Iodo-6-methyl-4-phenyl-2H-benzopyran (28). This compound was obtained as a 
brown oil: 1H NMR (300 MHz, CDCl3) δ 2.10 (s, 3H), 5.01 (s, 2H), 6.41 (s, 1H), 6.75 (d, J = 
8.2, Hz, 1H), 6.94 (d, J = 8.2, Hz, 1H), 7.17-7.20 (m, 2H), 7.40-7.46 (m, 3H); 13C NMR (75 
MHz, CDCl3) δ 20.8, 75.1, 91.4, 115.8, 124.1, 126.8, 128.2, 128.6, 129.5, 130.2, 131.0, 
140.1, 142.1, 151.1; IR (neat, cm-1) 3052, 2914, 1741, 1485, 1229, 999; HRMS m/z 
348.00155 (calcd C16H13IO, 348.00112). 
O
Ph
It-Bu
29  
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 6-tert-Butyl-3-iodo-4-phenyl-2H-benzopyran (29). This compound was obtained as 
a pale yellow solid: mp 84-86 oC; 1H NMR (300 MHz, CDCl3) δ 1.11 (s, 9H), 5.03 (s, 2H), 
6.63 (d, J = 2.4 Hz, 1H), 6.79 (d, J = 8.4 Hz, 1H), 7.16 (d, J = 2.4 Hz, 1H), 7.18-7.22 (m, 
2H), 7.37-7.48 (m, 3H); 13C NMR (75 MHz, CDCl3) δ 31.4, 34.3, 75.2, 90.9, 115.4, 123.5, 
123.8, 126.6, 128.3, 128.6, 129.5, 140.1, 142.4, 144.5, 151.1; IR (neat, cm-1) 3052, 2950, 
1485, 1357, 1229, 1004; HRMS m/z 390.04856 (calcd C19H19IO, 390.04807). 
O
Ph
IMeO
30  
 3-Iodo-6-methoxy-4-phenyl-2H-benzopyran (30). This compound was obtained as 
a pale brown solid: mp 81-82 oC; 1H NMR (300 MHz, CDCl3) δ 3.59 (s, 3H), 4.99 (s, 2H), 
6.19 (d, J = 2.9 Hz, 1H), 6.69 (dd, J = 8.7, 2.9 Hz, 1H), 6.79 (d, J = 8.7 Hz, 1H), 7.18-7.23 
(m, 2H), 7.38-7.46 (m, 3H); 13C NMR (75 MHz, CDCl3) δ 55.8, 75.3, 92.4, 112.5, 114.4, 
116.6, 125.1, 128.4, 128.8, 129.5, 140.0, 142.1, 147.4, 154.3; IR (neat, cm-1) 2991, 2924, 
2822, 1572, 1480, 1301, 1198; HRMS m/z 363.99663 (calcd C16H13IO2, 363.99603). 
O
Ph
ICl
31  
 6-Chloro-3-iodo-4-phenyl-2H-benzopyran (31). This compound was obtained as a 
brown solid: mp 89-90 oC; 1H NMR (300 MHz, CDCl3) δ 5.07 (s, 2H), 6.59 (d, J = 2.6 Hz, 
1H), 6.79 (d, J = 8.6 Hz, 1H), 7.09 (dd, J = 8.6, 2.5 Hz, 1H), 7.19 (dd, J = 7.8, 1.9 Hz 2H), 
7.43-7.48 (m, 3H); 13C NMR (75 MHz, CDCl3) δ 75.3, 93.0, 117.4, 125.3, 126.1, 126.7, 
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128.6, 129.0, 129.4, 129.5, 139.4, 141.2, 151.9; IR (neat, cm-1) 2919, 2848, 1477, 1403, 
1093, 638; HRMS m/z 367.94723 (calcd C15H10ClIO, 367.94649). 
O
Ph
IOHC
O
I
Ph
OHC+
32 33  
 3-Iodo-4-phenyl-2H-benzopyran-6-carbaldehyde (32) and 3-(iodophenyl-
methylene)-2,3-dihydrobenzofuran-5-carbaldehyde (33).  These compounds were 
obtained as a light brown solid as a 2:1 mixture: 1H NMR (300 MHz, CDCl3) δ 5.07 (s, 2H), 
5.19 (s, 1H), 6.95 (d, J = 8.3 Hz, 1H), 7.11 (d, J = 8.5 Hz, 3H), 7.19-7.23 (m, 3H), 7.31-7.40 
(m, 4H), 7.47-7.49 (m, 2H), 7.70 (dd, J = 8.3, 1.9 Hz, 1H), 7.90 (d, J = 8.7 Hz, 2H), 9.68 (s, 
1H), 9.92 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 75.5, 80.1, 92.7, 98.49, 99.4, 115.9, 116.9, 
123.8, 128.1, 128.5, 128.7, 128.8, 129.0, 129.1, 129.3, 130.7, 130.9, 131.8, 132.2, 139.2, 
141.0, 147.2, 158.6, 162.7, 190.7, 190.9; IR (neat, cm-1) 3057, 2827, 1690, 1598, 1234, 1157; 
HRMS m/z 361.98090 (calcd C16H11IO2, 361.98038). 
O
Ph
I
t-Bu
t-Bu
34  
 5,7-Di-tert-butyl-3-iodo-4-phenyl-2H-benzopyran (34). This compound was 
obtained as a yellow solid: mp 142-143 oC; 1H NMR (300 MHz, CDCl3) δ 0.89 (s, 9H), 1.31 
(s, 9H), 4.81 (s, 2H), 6.89 (d, J = 1.9 Hz, 1H), 7.12 (d, J = 2.1 Hz, 2H), 7.24-7.27 (m, 4H); 
13C NMR (75 MHz, CDCl3) δ 31.3, 32.1, 35.2, 36.8, 7.8, 85.0, 109.5, 119.9, 122.7, 127.6, 
128.0, 131.1, 143.7, 143.9, 149.8, 152.5, 157.2; IR (neat, cm-1) 2955, 2893, 1593, 1444, 
1403, 1004; HRMS m/z 446.11117 (calcd C23H27IO, 446.11067). 
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I
t-Bu
35  
 7-tert-Butyl-3-iodo-4-phenyl-2H-benzopyran (35). This compound was obtained as 
a light brown solid: mp 97-98 oC; 1H NMR (300 MHz, CDCl3) δ 1.30 (s, 9H), 5.09 (s, 2H), 
6.59 (d, J = 4.3 Hz, 1H), 6.83 (dd, J = 8.1, 1.8 Hz, 1H), 6.93 (d, J = 1.7 Hz, 1H), 7.21-7.25 
(m, 2H), 7.40-7.44 (m, 3H); 13C NMR (75 MHz, CDCl3) δ 31.3, 35.0, 75.3, 90.1, 113.3, 
118.7, 121.8, 126.1, 128.3, 128.7, 129.5, 140.2, 142.0, 153.1, 153.8; IR (neat, cm-1) 2965, 
2904, 2356, 1603, 1485, 1004; HRMS m/z 390.04856 (calcd C19H19IO, 390.04807). 
O
Ph
I
Cl
36  
 7-Chloro-3-iodo-4-phenyl-2H-benzopyran (36). This compound was obtained as a 
light brown solid: mp 90-91 oC; 1H NMR (300 MHz, CDCl3) δ 5.06 (s, 2H), 6.52 (d, J = 8.3 
Hz, 1H), 6.72 (dd, J = 8.4, 2.1 Hz, 1H), 6.85 (d, J = 2.1 Hz, 1H), 7.16-7.19 (m, 2H), 7.41-
7.48 (m, 3H); 13C NMR (75 MHz, CDCl3) δ 75.3, 91.2, 116.5, 121.9, 122.7, 127.4, 128.5, 
128.8, 129.4, 134.7, 139.6, 141.3, 154.0; IR (neat, cm-1) 2837, 1588, 1475, 1413, 1219, 999; 
HRMS m/z 367.94720 (calcd C15H10ClIO, 367.94649). 
O
Ph
I
Cl
37  
 5-Chloro-3-iodo-4-phenyl-2H-benzopyran (37). This compound was obtained as a 
light brown solid: mp 73-74 oC; 1H NMR (300 MHz, CDCl3) δ 4.94 (s, 2H), 6.88-6.91 (m, 
2H), 7.10 (t, J = 8.0 Hz, 1H), 7.17-7.20 (m, 2H), 7.34-7.38 (m, 3H); 13C NMR (75 MHz, 
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CDCl3) δ 76.0, 92.8, 115.2, 123.3, 125.0, 128.0, 128.1, 129.7, 129.9, 131.7, 140.4, 141.3, 
156.6; IR (neat, cm-1) 3052, 2937, 1588, 1444, 1239, 999; HRMS m/z 367.94725 (calcd 
C15H10ClIO, 367.94649). 
O
Ph
I
MeO O
Ph
I
OMe
+
38 39  
 3-Iodo-7-methoxy-4-phenyl-2H-benzopyran (38) and 3-iodo-5-methoxy-4-
phenyl-2H-benzopyran (39).  These compounds were obtained as a light brown solid as a 
2:3 mixture: 1H NMR (300 MHz, CDCl3) δ 3.22 (s, 3H), 3.76 (s, 2H), 4.93 (s, 2H), 5.04 (s, 
1H), 6.31 (dd, J = 8.6, 2.5 Hz, 1H), 6.37-6.47 (m, 2H), 6.50-6.62 (m, 2H), 7.12-7.21 (m, 4H), 
7.28-7.47 (m, 6H); 13C NMR (75 MHz, CDCl3) δ 55.6, 55.8, 75.3, 75.8, 87.0, 89.0, 101.7, 
106.1, 107.4, 109.2, 115.1, 117.8, 127.0, 127.6, 127.7, 128.2, 128.5, 128.6, 129.5, 130.2, 
140.2, 140.5, 141.8, 143.4, 154.7, 156.0, 156.1, 161.0; IR (neat, cm-1) 3016, 2934, 2827, 
1608, 1465, 1270; HRMS m/z 363.99664 (calcd C16H13IO2, 363.99603). 
O
I
40  
 4-(1-Cyclohexenyl)-3-iodo-2H-benzopyran (40). This compound was obtained as a 
light brown oil: 1H NMR (300 MHz, CDCl3) δ 1.65-1.76 (m, 4H), 2.05 (m, 2H), 2.18-2.20 
(m, 2H), 4.93 (s, 2H), 5.60-5.62 (m, 1H), 6.79 (dd, J = 8.0, 0.9 Hz, 1H), 6.86 (dt, J = 7.6, 1.1 
Hz, 1H), 7.06 (dd, J = 7.7, 1.5 Hz, 1H), 7.13 (dt, J = 7.7, 1.7 Hz, 1H); 13C NMR (75 MHz, 
CDCl3) δ 22.2, 22.8, 25.3, 27.6, 74.7, 89.2, 116.1, 121.7, 122.8, 125.6, 129.3, 129.5, 137.5, 
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143.5, 153.6; IR (neat, cm-1) 3027, 2914, 1598, 1475, 1209, 1034; HRMS m/z 338.01726 
(calcd C15H15IO, 338.01677). 
O
CH2OH
I
42  
 4-Hydroxymethyl-3-iodo-2H-benzopyran (42). This compound was obtained as a 
yellow solid: mp 62-63 oC; 1H NMR (300 MHz, CDCl3) δ 2.06 (s, 1H), 4.64 (s, 2H), 4.86 (s, 
2H), 6.82 (d, J = 8.0 Hz, 1H), 6.92-6.98 (m, 1H), 7.18 (dt, J = 8.0, 1.3 Hz, 1H), 7.41 (dd, J = 
7.7, 1.1 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 66.0, 75.0, 93.8, 116.4, 121.8, 122.1, 124.3, 
129.9, 137.3, 153.7; IR (neat, cm-1) 3334, 2934, 1480, 1444, 1219, 1009; HRMS m/z 
287.96514 (calcd C10H9IO2, 287.96473). 
O
Ph
I
43  
 3-Iodo-4-phenyl-2H-benzo[h]chromene (43). This compound was obtained as a 
light brown solid: mp 104-105 oC; 1H NMR (300 MHz, CDCl3) δ 5.25 (s, 2H), 6.77 (d, J = 
8.5 Hz, 1H), 7.21-7.25 (m, 3H), 7.42-7.50 (m, 5H), 7.68-7.71 (m, 1H), 8.17-8.20 (m, 1H); 
13C NMR (75 MHz, CDCl3) δ 75.6, 88.1, 118.8, 120.8, 122.2, 124.0, 124.3, 126.0, 127.1, 
127.7, 128.3, 128.7, 129.6, 134.3, 140.2, 142.7, 149.4; IR (neat, cm-1) 3055, 2923, 2847, 
1562, 1400, 1341; HRMS m/z 384.00158 (calcd C19H13IO, 384.00112). 
O
Ph
SePh
23  
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 4-Phenyl-3-phenylselenyl-2H-benzopyran (23). This compound was obtained as a 
brown oil: 1H NMR (300 MHz, CDCl3) δ 4.84 (s, 2H), 6.84-6.87 (m, 2H), 6.94 (t, J = 7.4 Hz, 
1H), 7.12-7.25 (m, 5H), 7.27-7.34 (m, 4H), 7.40-7.44 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 
29.9, 71.1, 115.3, 121.4, 124.0, 128.2, 128.4, 128.8, 129.1, 129.2, 129.2, 129.3, 129.6, 134.6, 
141.0, 158.4; IR (neat, cm-1) 3052, 2919, 1582, 1480, 1224, 1024; HRMS m/z 364.03707 
(calcd C21H16OSe, 364.03664). 
O
Me
SePh
41  
 4-Methyl-3-phenylselenyl-2H-benzopyran (41). This compound was obtained as a 
brown solid: mp 54-55 oC; 1H NMR (300 MHz, CDCl3) δ 2.66 (s, 3H), 4.80 (s, 2H), 6.83 (d, 
J = 7.9 Hz, 2H), 6.92 (t, J = 7.3 Hz, 1H), 7.20-7.26 (m, 4H), 7.42-7.44 (m, 2H); 13C NMR 
(75 MHz, CDCl3) δ 30.1, 72.1, 115.2, 121.3, 125.4, 127.6, 128.4, 129.5 (2C), 129.7, 130.2, 
132.5, 158.5; IR (neat, cm-1) 3057, 2914, 2847, 1593, 1485, 1229; HRMS m/z 302.02154 
(calcd C16H14OSe, 302.02099). 
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CHAPTER 2. PALLADIUM-CATALYZED ONE STEP SYNTHESIS OF 
ISOINDOLE-1,3-DIONES BY CARBONYLATIVE CYCLIZATION OF O-
HALOBENZOATES AND PRIMARY AMINES 
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 The palladium-catalyzed aminocarbonylation of ortho-halobenzoates produces 2-
substituted isoindole-1,3-diones in good yields.  This methodology provides a good one step 
approach to this important class of heterocycles and tolerates a variety of functional groups, 
including methoxy, alcohol, ketone and nitro groups. 
 
Introduction 
Isoindole-1,3-diones, commonly known as phthalimides, are key structural units of a 
variety of biologically important compounds, many of which are pharmaceutically 
significant.  The drug thalidomide [2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione], was 
originally developed as a sedative, an alternative to barbiturates, but was withdrawn from the 
market in the 1960s, because it displayed teratogenic properties.1  Recently, interest in this 
compound has increased, because of its interesting anti-inflammatory and antiangiogenic2 
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properties and its possible use in the treatment of acquired immunodeficiency syndrome 
(AIDS) caused by the human immunodeficiency virus (HIV),3,4 leprosy5 and other diseases.6-
8  The isoindole-1,3-dione N-phthaloyl-L-glutamic acid is a selective glutamate receptor 
agonist,9 while 1,8-naphthalimide is known for its cytotoxicity against the growth of human 
cancer cultured cells.10  Some isoindole-1,3-dione derivatives are active in reducing the 
growth of colon adenocarcinoma, osteosarcoma and KB nasopharynx.11  Isoindole-1,3-diones 
are also known for their antiviral,12 anti-inflammatory,13 Chk1 inhibitory,14 sedative,15 
bactericidal and fungicidal16 properties.  They also find important applications as synthetic 
intermediates in the dye,17 pesticide18 and polymer19 industries.   
Due to their biological, pharmaceutical and industrial importance, the synthesis of 
isoindole-1,3-diones has received considerable attention in the literature.  The most common 
method reported in the literature for the synthesis of isoindole-1,3-diones involves the 
reaction of a phthalic acid anhydride and a primary amine.20  Syntheses of isoindole-1,3-
diones have also been reported using other approaches, including the ammoxidation of o-
xylenes by vanadium/titanium/oxygen catalysis and subsequent oxidation of intermediate o-
tolunitriles,21 microwave irradiation of N-hydroxymethylphthalimides with aryl amines or 
phthalic anhydrides with urea, the microwave-induced cleavage of solid-supported o-
amidoesters,22 the palladium-catalyzed carbonylation of o-haloamides, and a combination of 
carbonylation and nitrogenation of o-halophenyl alkyl ketones.23   
The development of new methods for the simultaneous formation of both carbon-
carbon and carbon-heteroatom bonds in a single step is quite advantageous to the organic 
chemist, since it allows the assembly of complex molecules from simple precursors.  
Transition metal-catalyzed reactions, especially palladium-catalyzed processes, which 
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involve the insertion of unsaturated molecules, such as carbon monoxide, alkynes and 
alkenes, into a carbon-metal bond are an important step towards this goal.  In the past couple 
of years, we have developed in our laboratories the palladium-catalyzed annulation of dienes 
and internal alkynes by aromatic and vinylic halides bearing a neighboring nucleophilic 
substituent as an efficient way to synthesize a wide variety of carbocyclic and heterocyclic 
compounds,24 including indoles,25 isoquinolines,26 benzofurans,27 benzopyrans,27 
isocoumarins,27,28 α-pyrones,28,29 indenones,30 naphthalenes,31 and phenanthrenes.32  CO 
insertion into the aryl-palladium bond to form an acylpalladium complex is a ubiquitous 
process in organic synthesis.33  The resulting acylpalladium complexes react with various 
nucleophiles to give aryl carbonyl compounds.  When nitrogen acts as the nucleophile, the 
process is aminocarbonylation,34 which is an important method for the synthesis of amides.  
While many examples of such processes have been reported to form acyclic amides,35 
relatively few have been reported for the formation of cyclic amides.  Ban et al. have 
reported the palladium-catalyzed formation of isoindole-1,3-diones from o-bromobenzamides 
and CO,36 while Perry et al. have prepared isoindole-1,3-diones from o-dihaloarenes in the 
presence of CO, a primary amine, a catalytic amount of palladium, and a base in dipolar 
aprotic solvents.37  However, these routes either limit the groups that can be introduced on 
the nitrogen of the isoindole-1,3-dione, because one first needs to prepare the starting 
benzamides, or they require high pressures of CO and specialized equipment, like pressure 
reactors.  To the best of our knowledge, the synthesis of N-substituted isoindole-1,3-diones 
by the palladium-catalyzed aminocarbonylation of simple ortho-halobenzoates has not been 
reported previously.  We report herein a number of examples of such a one step synthesis of 
this important class of heterocycles in good yields using readily available starting materials. 
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Results and Discussion 
The focus of our early studies was the palladium-catalyzed aminocarbonylation of 
ortho-halobenzoates to give 2-substituted isoindole-1,3-diones in good yields.  Methyl 2-
iodobenzoate (1a) was used as a model system for optimization of the reaction conditions 
using benzylamine (2a) as the amine.  Early in this work, the reaction was run with 0.5 mmol 
of 1a, 1.2 equiv of benzylamine, 5 mol % Pd(OAc)2, 10 mol % PPh3, 2 equiv of Cs2CO3 as a 
base in 6 ml of toluene at 95 oC under one atmosphere of CO to obtain a 75% isolated yield 
of the desired 2-benzylisoindole-1,3-dione (3a) (eq. 1).  The yield of the desired product 3a 
 
N
O
O
PhI
OMe
O
1.2 PhCH2NH2 +
5 mol % Pd(OAc)2
10 mol % PPh3
+
toluene
95 oC, 24 h
CO (1 atm)
75%
1a 2a 3a
(1)2.0 Cs2CO3
 
 
slightly increased to 76% when the amount of palladium catalyst and the triphenylphosphine 
ligand was increased to 10 mol % and 20 mol % respectively (Table 1, entry 1).  No desired 
product was obtained when the reaction was carried out in the absence of the ligand PPh3. 
 
Table 1. Optimization of the Palladium-Catalyzed Carbonylative Cyclization of Methyl 2-
Iodobenzoate and Benzylamine using various Phosphine Ligands (eq. 1)a 
entry ligand (20 mol %)                                                                               % isolated yield 
1 PPh3 76 
2 P(o-tolyl)3 14 
3 Tri-(2-methoxyphenyl)phosphine 38 
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Table 1. Continued 
entry ligand (20 mol %)                                                                               % isolated yield 
4 Tricyclohexylphosphine 82 
5 Triethylphosphine 39 
6 Tri-(2-furyl)phosphine 66 
7 Diphenyl-2-pyridylphosphine 84 
8 (2-Biphenyl)di-tert-butylphosphine 31 
9 Tri-t-butylphosphine 53 
10 2-Dicyclohexylphosphino-2',6'-dimethoxybiphenyl (S-PHOS) 66 
11 2-Dicyclohexylphosphino-2′-(N,N-dimethylamino)biphenyl (DavePhos)  64 
12 (±)-2,2'-Bis(diphenylphosphino)-1,1'-binaphthalene (BINAP) 19 
13 2,2'-Bis(di-p-tolylphosphino)-1,1'-binaphthalene (Tol-BINAP)  71 
14 4,5-Bis(diphenylphosphino)-9,9-dimethylxanthene (Xantphos) 78 
15 1,1'-Bis(diphenylphosphino)ferrocene (dppf) 17 
16 1,1-Bis(diphenylphosphino)methane (dppm) 34 
17 1,2-Bis(diphenylphosphino)ethane (dppe) ~5 
18 1,3-Bis(diphenylphosphino)propane (dppp)  91 
19 1,4-Bis(diphenylphosphino)butane 81 
20 1,5-Bis(diphenylphosphino)pentane 64 
a Representative procedure:  methyl 2-iodobenzoate (0.5 mmol), benzylamine (1.2 equiv), Pd(OAc)2 (10 mol 
%), ligand (20 mol %), Cs2CO3 (2 equiv) and toluene (6 mL) were placed in a 4 dram vial.  The vial was 
sealed and flushed with CO.  The reaction was then stirred at 95 oC for 24 h with a CO balloon on top of the 
vial. 
 
Noting the importance of the ligand in the reaction, various ligands were screened 
with the aim of increasing the yield of the imide.  More sterically hindered triarylphosphines 
gave significantly lower yields (entries 2 and 3).  More basic tricyclohexylphosphine gave a 
high yield (entry 4), but PEt3 gave a poor yield (entry 5).  Heterocyclic tri-(2-furyl)phosphine 
afforded a modest yield of imide (entry 6).  Diphenyl-2-pyridylphosphine improved the yield 
dramatically to 84% (entry 7), but other bulky monodentate ligands gave only modest yields 
(entries 8-11). 
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Since the yields of imide are highly dependant on the ligands employed, we decided 
to screen bidentate ligands under similar reaction conditions.  BINAP and dppf gave poor 
yields, while Tol-BINAP and Xantphos gave 71% and 78% yields respectively, which were 
close to those obtained with the parent triphenylphosphine (entries 12-15).  The ligands dppm 
and dppe reduced the yields drastically to 34% and 5% respectively (entries 16 and 17), 
while dppp improved the yield to 91% (entry 18).  With further elongation of the carbon 
chain of the bidentate ligand, the yields decreased.  Thus, 1,4-bis(diphenylphosphino)butane 
and 1,5-bis(diphenylphosphino)pentane gave 81% and 64% yields respectively (entries 19 
and 20). 
With dppp as the ligand of choice, the reaction was carried out in various solvents.  
Reactions in the low boiling polar solvents CH3CN and CH3OH had to be carried out at 
lower temperatures and they did not give the desired product (Table 2, entries 1 and 2).  The 
higher boiling polar solvents DMSO and DMF gave extremely poor yields at 95 oC (entries 3 
and 4).  Nitromethane gave a 10% yield of the desired product at 95 oC (entry 5), while THF 
gave a 42% yield of the desired product at the lower temperature of 60 oC (entry 6).  
Reaction in toluene as the solvent at the lower temperature of 80 oC  reduced the yield to 
79% (entry 7).  A reduction in the amount of phosphine ligand to 10 mol % reduced the yield 
to 76% (entry 8).  When the reaction was carried out with 10 mol % of the dppp ligand and 5 
mol % of the palladium catalyst, the yield increased to 89% (entry 9), indicating that the ratio 
1:2 of palladium catalyst to phosphine ligand works better than a ratio of 1:1.  Maintaining 
the ratio of the palladium catalyst and phosphine at 1:2, but reducing the amount of 
palladium to 2 mol %, the yield dropped to 78% (entry 10).  An excess of the ligand reduced 
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the yield further to 49% (entry 11).  Excess ligand with 5 mol % of palladium also gave a 
poor yield of 53% (entry 12).  The base Cs2CO3 proved to be very important for the reaction  
 
Table 2. Optimization of the Palladium-Catalyzed Carbonylative Cyclization of Methyl 2-
Iodobenzoate and Benzylamine with dppp as the Ligand (eq. 1)a 
entry Pd(OAc)2
(mol %) 
dppp 
(mol %) 
Cs2CO3 
(equiv) 
solvent time 
(h) 
temp. 
(oC) 
% yieldb 
1 10 20 2.0 CH3CN 24 75 0 
2 10 20 2.0 CH3OH 24 60 0 
3 10 20 2.0 DMSO 24 95 ~5c 
4 10 20 2.0 DMF 24 95 ~5c 
5 10 20 2.0 CH3NO2 24 95 10 
6 10 20 2.0 THF 24 60 42 
7 10 20 2.0 PhCH3 24 80 79 
8 10 10 2.0 PhCH3 24 95 76 
9 5 10 2.0 PhCH3 24 95 89 
10 2 4 2.0 PhCH3 24 95 78 
11 2 10 2.0 PhCH3 24 95 49 
12 5 20 2.0 PhCH3 24 95 53 
13 5 10 1.5 PhCH3 24 95 73 
14 5 10 3.0 PhCH3 24 95 90 
15 5 10 2.0 PhCH3 12 95 78 
a Representative procedure:  methyl 2-iodobenzoate (0.5 mmol), benzylamine (1.2 equiv), Pd(OAc)2 , 
dppp, Cs2CO3 and the solvent (6 mL) were placed in a 4 dram vial.  The vial was sealed and flushed with 
CO.  The reaction was then stirred at 95 oC for the indicated time with a CO balloon on top of the vial. b 
Isolated yields. c GC yields. 
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as the yield was reduced to 73% when using only 1.5 equiv of the base (compare entries 9 
and 13).  Increasing the amount of the base afforded no significant increase in the yield 
(entry 14).  A reduced reaction time gave a lower yield of 78% (entry 15).  Thus, our 
optimized conditions for the carbonylative cyclization are 0.5 mmol of 1a, 1.2 equiv of 2a, 5 
mol % of Pd(OAc)2, 10 mol % of dppp, 2 equiv of Cs2CO3 in 6 ml of toluene at 95 oC under 
one atmosphere of CO for 24 h. 
After obtaining our best reaction conditions for aminocarbonylation, we examined the 
scope of this reaction on various substrates.  The ortho-halo esters 1a, 1b, 1d and 1e were 
obtained from commercial sources, while 1c was prepared according to a literature 
procedure.38  The model system under our optimized conditions with benzylamine gave an 
89% isolated yield of the desired product 3a (Table 3, entry 1).  Compound 3a was obtained 
in a slightly lower 85% yield, when the reaction was carried out on a larger scale (entry 2).  
A reaction with methyl 2-bromobenzoate (1b) gave a reduced yield of 55% (entry 3).  This is 
probably due to the fact that the oxidative insertion of Pd(0) into a C-Br bond is less facile 
than into a C-I bond.  For similar reasons, when two electron-donating methoxy groups were 
placed on the ortho-iodobenzoate, the yield was reduced to 46% (entry 4).  Electron donation 
by methoxy substituents is known to slow oxidative addition to aromatic halides.  The 
presence of an inductively electron-withdrawing bromo-substituent  para to the iodo group in 
the benzoate ester 1d sharply lowered the yield to 51% when compared with the parent 
system (entry 5).  The presence of a strong electron-withdrawing NO2 group para to the 
bromo group in the benzoate ester 1e increased the yield from 55% to 71% (compare entries 
3 and 6). 
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We have also examined the reactivity of an ester bearing a vinylic halide.  When 
methyl 2-bromocyclohept-1-enecarboxylate was subjected to aminocarbonylation under our 
optimized conditions using benzyl amine, the desired product was obtained in only a poor 
yield (<15%). 
 
Table 3. Synthesis of Isoindole-1,3-diones by the Aminocarbonylative Cyclization of ortho-
Halobenzoate Esters.a 
Entry o-halo ester amine        product % isolated yield 
1 OMe
O
I
1a  
H2N
 
2a 
N
O
O
3a  
89 
2 1a 2a 3a 85b 
3 OMe
O
Br
1b  
2a 3a 55 
4 OMe
O
I
MeO
MeO
1c  
2a N
O
O
MeO
MeO
3b  
46 
5 OMe
O
I
Br
1d  
2a N
O
O
Br
3c  
51 
6 OMe
O
Br
O2N
1e  
2a N
O
O
O2N
3d  
71 
7 1a 
H2N
 
2b 
N
O
O3e  
81 
8 1a H2N
 
2c 
N
O
O3f  
92 
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Table 3. continued 
Entry o-halo ester amine        product % isolated Yield 
9 1a 
H2N
OH
 
2d 
N
O
O
OH
3g  
25 
10 1a 2d       3g 41c 
11 1a H2N
OMe  
2e 
N
O
O
OMe3h  
68 
12 1a H2N
O
O
 
2f 
N
O
O
O
O
3i  
61 
13 1a 
H2N
O Me
 
2g 
N
O
O
O
Me3j  
77 
14 1a 
H2N S
 
2h 
N
O
O
S
3k  
71 
15 1a H2N Me
 
2i 
N
O
O
Me
3l  
79 
16 1a H2N
Me
Me2j  
N
O
O3m
Me
Me  
77 
17 1a H2N F
 
2k 
N
O
O
F
3n  
71 
18 1a H2N Br
 
2l 
N
O
O
Br
3o  
68 
19 1a H2N I
 
2m 
N
O
O
I
3p  
57 
20 1a 
H2N
O
 2n 
N
O
O
O
3q  
25 
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Table 3. continued 
Entry o-halo ester amine        product % isolated yield 
21 1a H2N NO2  
2o      
N
H
CO2Me
C6H4NO2-p3r  
62 
22 1a 
NH2
CF3  
2p      
N
H
CO2Me
C6H4CF3-m3s  
61 
23 1a 
N
NH2
 
2q      
N
CO2Me
N
H
3t  
57 
24 1a 
NH2
 
2r      
N
CO2Me
H
3u  
55 
25 1a 
NH2
OMeMeO
 
2s     
N
CO2Me
OMe
H
3v
MeO
 
61 
26 1a 
NH2
OMe
 
2t     
N
CO2Me
OMe
H
3w  
62 
27 1a 
NH2
Me
 
2u     
N
CO2Me
Me
H
3x  
55 
 
 
     
 
a Representative procedure:  ortho-halobenzoate ester 1 (0.5 mmol), amine 2 (1.2 equiv), 
Pd(OAc)2 (5 mol %), dppe (10 mol %), Cs2CO3 (2 equiv) and toluene (6 mL) were placed in a 
round bottom flask.  The flask was sealed and flushed with CO.  The reaction was stirred at 95 
oC for 24 h with a CO balloon on top of the flask.  b The reaction was scaled up to 2 mmol of 
halo ester.  c The reaction was carried out using 10 equiv of amine. 
 
We also studied the scope of the reaction using various amines.  The reaction of 1a 
with phenethylamine (2b) gave the desired product 3e in an 81% yield (entry 7).  The more 
hindered aliphatic amine cyclohexyl amine gave an excellent 92% yield of the desired 
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product 3f (entry 8).  The lower boiling alcohol-containing amine 2d gave a poor yield of 
25% (entry 9), but the yield was increased to 41% when the reaction was carried out with an 
excess of the amine (entry 10).  The reaction using benzyl amine bearing an electron-
donating para methoxy group gave a 68% yield of the desired product 3h (entry 11).  
Oxygen- and sulfur-containing heterocyclic amines worked well under our optimized 
conditions (entries 12-14).  The nitrogen-containing heterocyclic amines N-(3-
aminopropyl)morpholine and N-(3-aminopropyl)imidazole failed to give the desired products 
under our reaction conditions for reasons not presently understood. 
After screening the above-mentioned aliphatic amines, we decided to study the scope 
of the reaction with aromatic amines.  Amines 2i and 2j with electron-donating methyl 
groups gave 79% and 77% yields of the desired products 3l and 3m respectively (entries 15 
and 16).  4-Aminophenol failed to give the desired product apparently due to solubility 
problems.  An electron-withdrawing fluoro group did not have much of an effect on the yield 
(entry 17).  But the presence of a bromo or iodo substituent at the para position of the aniline 
gave somewhat lower yields of 68% and 57% respectively (entries 18 and 19).  It is possible 
that the desired products are perhaps undergoing further reaction with palladium.  The 
presence of an electron-withdrawing ketone group on the amine drastically reduced the yield 
of the desired product 3q to 25% (entry 20).  The presence of strong electron-withdrawing 
NO2 and CF3 groups on the amine failed to give the desired cyclic products.  Instead these 
substrates formed 3r and 3s in 62% and 61% yields respectively (entries 21 and 22).  Amine 
2q also failed to form the desired cyclic product (entry 23).  In order to establish if the reason 
this substrate failed to cyclize was its slightly electron-deficient nature or its steric bulk, we 
studied the aminocarbonylation of 1-naphthylamine (2r).  To our surprise, this substrate also 
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failed to cyclize.  Instead we obtained ester 3u in a 55% isolated yield (entry 24).  We have 
also examined the reaction of amine 2s to confirm that sterically hindered aromatic amines 
fail to give the desired cyclic isoindole-1,3-diones under our reaction conditions.  Again an 
amino ester was obtained (entry 25).  Even the simple mono ortho-substituted amines 2t and 
2u failed to give the desired cyclic products, but afforded decent yields of the corresponding 
amino esters (entries 26 and 27).   
We believe that the mechanism of these carbonylative cyclizations involves a two 
step process: (1) palladium-catalyzed formation of the corresponding ortho-
amidocarboxylates, followed by (2) base-catalyzed cyclization of these ortho-
amidocarboxylates to the cyclic isoindole-1,3-diones (Scheme 4).  Palladium undergoes 
oxidative insertion into the carbon-halogen bond to give Pd(II) intermediate I, which then 
inserts CO to form the acylpalladium complex II.  The acylpalladium complex then reacts 
with the amine to give the ortho-amidocarboxylate III.  This species then participates in a 
base-catalyzed cyclization.  The base extracts the amide proton to give anionic nitrogen 
species IV, which attacks the ester carbonyl to afford cyclic intermediate V, which results in 
formation of the final isoindole-1,3-dione VI by loss of a methoxy group.  The insertion of 
CO in the Pd(II) intermediate I to form the acylpalladium complex II is a reversible process.  
We believe that the desired ortho-amidocarboxylate III is obtained in the presence of a more 
nucleophilic amine by trapping the acylpalladium intermediate II.  Amines with strong 
electron-withdrawing groups, due to their poor nucleophilicity, fail to trap the acylpalladium 
complex II to form the corresponding ortho-amidocarboxylate III, but apparently they react 
with the Pd(II) intermediate I to form the corresponding amino ester (refer to Table 3, entries 
21 and 22).  Amino ester products 3t to 3x (refer to Table 3, entries 23 to 27) are apparently  
 
51
Scheme 4 
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formed by more rapid reaction of the intermediate arylpalladium intermediate I directly with 
the more hindered amine rather than the acylpalladium intermediate II.  
The isoindole-1,3-diones obtained by this simple palladium-catalyzed 
aminocarbonylation process appear to be promising intermediates for the preparation of more 
highly substituted isoindole-1,3-diones.  To expand the scope of our chemistry, we subjected 
isoindole-1,3-dione 3c to a palladium/copper-catalyzed Sonogashira reaction to obtain an 
excellent 86% isolated yield of the substituted isoindole-1,3-dione 4 (Scheme 5).  The Suzuki 
coupling of 3c with p-methoxyphenylboronic acid gave a 51% yield of the desired product 5.   
 
Conclusions 
A range of isoindole-1,3-diones have been obtained by the one step palladium-
catalyzed aminocarbonylation of simple o-halobenzoate esters starting materials that are 
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Scheme 5 
Et3N, 65 
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3c
 
 
readily available or easily synthesized.  The reaction conditions are mild and the products are 
easy to isolate in good yields.  A halogen moiety can also be introduced into the products, 
which provides a useful handle for further functionalization of the resulting heterocycles.  
The Sonogashira and Suzuki products 4 and 5 have been obtained in good to excellent yields 
in this manner.  Our methodology tolerates a number of functional groups, including alcohol, 
ketone, methoxy and nitro groups, and works well for both aliphatic and aromatic primary 
amines.  The methodology provides a very convenient one step approach to this important 
class of heterocycles.  
 
Experimental Section  
 General.  The 1H and 13C NMR spectra were recorded at 300 and 75.5 MHz or 400 
and 100 MHz respectively.  Thin layer chromatography was performed using 60 mesh silica 
gel plates, and visualization was effected with short wavelength UV light (254 nm).  All 
melting points are uncorrected.  All high resolution mass spectra were recorded using EI at 
70 eV.  All reagents were used directly as obtained commercially unless otherwise noted. 
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General procedure for the palladium-catalyzed carbonylative cyclization of 
ortho-halobenzoates and primary amines.  To a solution of 0.5 mmol of the ortho-
halobenzoate in PhCH3 (6 ml) was added the primary amine (1.2 equiv), Pd(OAc)2 (5 mol 
%), dppp (10 mol %) and Cs2CO3 (2.0 equiv).  The flask was then sealed and flushed with 
CO.  A balloon filled with CO was placed on the top of the flask and the reaction was stirred 
at 95 oC for 24 h.  After the reaction was over, the resulting solution was diluted with EtOAc 
(10 ml) and filtered through celite.  The celite was thoroughly washed with EtOAc (15 ml) to 
ensure complete extraction of the crude product.  The combined EtOAc fractions were dried 
over anhydrous Na2SO4 and concentrated under vacuum to yield the crude product, which 
was purified by flash chromatography on silica gel using ethyl acetate/hexanes as the eluent.  
Solid products were further recrystallized from ethanol. 
 
N
O
O
Ph
4  
2-Benzyl-5-(phenylethynyl)isoindoline-1,3-dione (4).  This compound was prepared 
by the following procedure.  To a solution of 63 mg of 2-benzyl-5-bromoisoindoline-1,3-
dione (3c) (0.2 mmol) in Et3N (2 ml) was added PdCl2(PPh3)2 (2 mol %) and CuI (1.5 mol 
%), and the mixture was stirred for 10 min under Ar.  0.3 Mmol of phenylacetylene dissolved 
in 0.5 mL of Et3N was then added dropwise and the reaction mixture was allowed to stir at 
60 oC for 24 h.  The reaction was monitored by TLC.  After the reaction was over, the 
resulting solution was diluted with H2O (5 ml) and extracted with ethyl acetate (3 x 10 mL).  
The combined ethyl acetate fractions were dried over anhydrous Na2SO4 and concentrated 
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under vacuum to yield the crude product, which was purified by flash chromatography on 
silica gel using hexanes/ethyl acetate as the eluent to obtain the desired compound 4 in an 
86% yield as a pale brown solid: mp 166-167 oC; 1H NMR (400 MHz, CDCl3) δ 4.84 (s, 2H), 
7.25-7.44 (m, 8H), 7.54-7.56 (m, 2H), 7.81 (d, J = 0.6 Hz, 2H), 7.95 (s, 1H); 13C NMR (100 
MHz, CDCl3) δ 41.9, 87.9, 94.0, 122.2, 123.5, 126.3, 128.0, 128.7, 128.8, 128.9, 129.4, 
129.7, 130.9, 132.0, 132.5, 136.3, 137.0, 167.5, 167.6; IR (neat, cm-1) 2924, 1708, 1627, 
1436, 1359, 1106, 955; HRMS m/z 337.11077 (calcd C23H15NO2, 337.11028). 
N
O
O
MeO
5  
2-Benzyl-5-(4-methoxyphenyl)isoindoline-1,3-dione (5).  This compound was 
prepared by the following procedure.  To 63 mg of 2-benzyl-5-bromoisoindoline-1,3-dione 
(3c) (0.2 mmol) was added 46 mg (1.5 equiv) of 4-methoxyphenylboronic acid, PdCl2 (5 mol 
%), KHCO3 (1.5 equiv) and 4:1 DMF/H2O (5 ml).  The reaction mixture was stirred at 80 oC 
for 12 h.  The resulting solution was cooled to room temperature, diluted with H2O (5 ml) 
and extracted with ethyl acetate (3 x 15 mL).  The combined ethyl acetate fractions were 
washed with brine, dried over anhydrous Na2SO4, and concentrated under vacuum to yield 
the crude product, which was further purified by flash chromatography on silica gel using 
hexanes/ethyl acetate as the eluent to obtain the desired compound 5 in a 51% yield as a 
white solid: mp 167-168 oC; 1H NMR (400 MHz, CDCl3) δ 3.86 (s, 3H), 4.86 (s, 2H), 7.01 
(d, J = 8.8 Hz, 2H), 7.24-7.34 (m, 3H), 7.44 (d, J = 7.2 Hz, 2H), 7.57 (d, J = 8.6 Hz, 2H), 
7.85 (d, J = 0.8 Hz, 2H), 8.01 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 41.8, 55.6, 114.8, 
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121.5, 123.9, 127.9, 128.6, 128.7, 128.8, 129.9, 131.5, 132.0, 133.2, 136.6, 147.2, 160.5, 
168.2, 168.3; IR (neat, cm-1) 2916, 1774, 1700, 1596, 1250, 1033; HRMS m/z 343.12126 
(calcd C22H17NO3, 343.12084). 
Characterization data:  
N
O
O3a  
2-Benzylisoindoline-1,3-dione (3a).  This compound was obtained as a white solid: 
mp 119-121 oC (lit.22d 118-120 oC); 1H NMR (400 MHz, CDCl3) δ 4.84 (s, 2H), 7.25-7.33 
(m, 3H), 7.43 (d, J = 7.1 Hz, 2H), 7.67-7.70 (m, 2H), 7.82-7.84 (m, 2H); 13C NMR (100 
MHz, CDCl3) δ 41.7, 115.4, 123.4, 127.9, 128.7, 132.2, 134.1, 136.5, 168.1; IR (neat, cm-1) 
2926, 2253, 1770, 1712, 1394, 909; HRMS m/z 237.07927 (calcd C15H11NO2, 237.07898). 
N
O
O
MeO
MeO
3b  
2-Benzyl-5,6-dimethoxyisoindole-1,3-dione (3b).  This compound was obtained as a 
white solid: mp 222-223 oC; 1H NMR (400 MHz, CDCl3) δ 3.98 (s, 6H), 4.80 (s, 2H), 7.23-
7.27 (m, 3H), 7.29-7.33 (m, 2H), 7.40-7.41 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 41.7, 
56.8, 105.5, 125.7, 127.8, 128.6, 128.8, 136.8, 153.9, 168.4; HRMS m/z 297.10057 (calcd 
C17H15NO4, 297.10011).  
N
O
O
Ph
Br
3c  
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2-Benzyl-5-bromoisoindole-1,3-dione (3c).  This compound was obtained as a white 
solid: mp 121-123 oC; 1H NMR (400 MHz, CDCl3) δ 4.83 (s, 2H), 7.24-7.33 (m, 3H), 7.41 
(d, J = 6.8 Hz, 2H), 7.69 (d, J = 8.0 Hz, 1H), 7.83 (dd, J = 8.0, 1.5 Hz, 1H), 7.96 (d, J = 1.1 
Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 42.0, 115.5, 124.8, 126.9, 128.1, 128.8, 128.9, 
130.7, 133.9, 136.1, 137.1, 166.8, 167.3; HRMS m/z 314.99000 (calcd C15H10O2NBr, 
314.98949). 
N
O
O
O2N
3d
 
2-Benzyl-5-nitroisoindole-1,3-dione (3d).  This compound was obtained as a white 
solid: mp 156-158 oC; 1H NMR (400 MHz, CDCl3) δ 4.88 (s, 2H), 7.26-7.32 (m, 3H), 7.43 
(d, J = 6.7 Hz, 2H), 8.03 (d, J = 7.9 Hz, 1H), 8.58 (d, J = 7.8, 1H), 8.65 (s, 1H); 13C NMR 
(100 MHz, CDCl3) δ 42.4, 118.9, 124.7, 128.3, 128.94, 128.99, 129.4, 133.6, 135.6, 136.6, 
151.8, 165.7, 166.0; HRMS m/z 282.06060 (calcd C15H10O4N2, 282.06442). 
N
O
O3e  
2-(Phenethyl)isoindole-1,3-dione (3e).  This compound was obtained as a white 
solid: mp 130-132 oC (lit.39 131-132 oC); 1H NMR (400 MHz, CDCl3) δ 2.98 (t, J = 7.6 Hz, 
2H), 3.91 (t, J = 7.7 Hz, 2H), 7.18-7.29 (m, 5H), 7.67-7.70 (m, 2H), 7.80-7.82 (m, 2H); 13C 
NMR (100 MHz, CDCl3) δ 34.7, 39.4, 123.3, 126.7, 128.6, 128.9, 132.1, 134.0, 138.1, 168.2; 
HRMS m/z 251.09493 (calcd C16H13O2N, 251.09463). 
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N
O
O3f  
2-Cyclohexylisoindole-1,3-dione (3f).  This compound was obtained as a white 
solid: mp 170-172 oC (lit.40 169-171 oC); 1H NMR (400 MHz, CDCl3) δ 1.22-1.42 (m, 3H), 
1.68-1.74 (m, 3H), 1.86 (d, J = 13.2 Hz, 2H), 2.15-2.25 (m, 2H), 4.07-4.15 (m, 1H), 7.68-
7.70 (m, 2H), 7.80-7.82 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 25.3, 26.2, 30.0, 51.0, 
123.1, 132.2, 133.8, 168.6; HRMS m/z 229.11047 (calcd C14H15O2N, 229.11028). 
N
O
O
OH
3g  
2-(1-Hydroxymethyl-2-methylpropyl)isoindole-1,3-dione (3g).  This compound 
was obtained as a colorless oil: 13C NMR (100 MHz, CDCl3) δ 20.1, 20.2, 27.1, 60.1, 62.4, 
123.5, 131.7, 134.3, 169.5; HRMS m/z 233.10548 (calcd C13H15O3N, 233.10519). The 1H 
NMR spectrum matches the literature data.41 
N
O
O
OMe
3h
 
2-(4-Methoxybenzyl)isoindole-1,3-dione (3h).  This compound was obtained as a 
white solid: mp 129-131 oC; HRMS m/z 267.09005 (calcd C16H13O3N, 267.08954). The 1H 
and 13C NMR spectra match the literature data.22c 
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N
O
O
O
O3i
 
2-(Benzo[1,3]dioxol-5-ylmethyl)isoindole-1,3-dione (3i).  This compound was 
obtained as a white solid: mp 133-135 oC; 1H NMR (400 MHz, CDCl3) δ 4.74 (s, 2H), 5.90 
(s, 2H), 6.73 (d, J = 8.4 Hz, 1H), 6.92 (d, J = 7.0 Hz, 2H), 7.68-7.70 (m, 2H), 7.81-7.84 (m, 
2H); 13C NMR (100 MHz, CDCl3) δ 41.5, 101.2, 108.3, 109.3, 122.4, 123.4, 130.2, 132.1, 
134.0, 147.2, 147.8, 168.0; HRMS m/z 281.06930 (calcd C16H11O4N, 281.06881). 
N
O
O
O
Me
3j
 
2-(5-Methyl-2-furanylmethyl)isoindole-1,3-dione (3j).  This compound was 
obtained as a pale yellow solid: mp 80-82 oC; 1H NMR (400 MHz, CDCl3) δ 2.22 (s, 3H), 
4.79 (s, 2H), 5.87 (d, J = 2.1 Hz, 1H), 6.24 (d, J = 3.0 Hz, 1H), 7.69-7.71 (m, 2H), 7.83-7.85 
(m, 2H); 13C NMR (100 MHz, CDCl3) δ 13.7, 34.5, 106.5, 109.7, 123.4, 132.1, 134.0, 147.5, 
152.2, 167.7; IR (neat, cm-1) 3467, 2924, 1770, 1724, 1421, 1382; HRMS m/z 241.07434 
(calcd C14H11O3N, 241.07389). 
N
O
O
S
3k  
2-(2-Thiophen-2-ylethyl)isoindole-1,3-dione (3k).  This compound was obtained as 
a white solid: mp 130-131 oC (lit.42 128-130 oC); 13C NMR (100 MHz, CDCl3) δ 28.7, 39.4, 
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123.3, 124.2, 125.7, 127.0, 132.0, 134.0, 140.0, 168.1; HRMS m/z 257.05140 (calcd 
C14H11O2NS, 257.05105). The 1H NMR spectrum matches the literature data.42 
N
O
O
Me
3l  
2-p-Tolylisoindole-1,3-dione (3l).  This compound was obtained as a colorless solid: 
mp 204-206 oC (lit.43 205-206 oC); 13C NMR (100 MHz, CDCl3) δ 29.8, 123.8, 126.6, 129.1, 
129.9, 131.9, 134.4, 138.3, 167.5; IR (neat, cm-1) 2915, 2847, 1715, 1515, 1294, 1097; 
HRMS m/z 237.07927 (calcd C15H11O2N, 237.07898). The 1H NMR spectrum matches the 
literature data.43 
N
O
O
Me
Me3m  
2-(3,5-Dimethylphenyl)isoindole-1,3-dione (3m).  This compound was obtained as a 
white solid: mp 133-135 oC (lit.44 133 oC); 13C NMR (100 MHz, CDCl3) δ 21.4, 123.7, 124.6, 
130.2, 131.4, 131.9, 134.4, 139.0, 167.5; IR (neat, cm-1) 2921, 1713, 1609, 1373, 1171, 714; 
HRMS m/z 251.09507 (calcd C16H13O2N, 251.09463). The 1H NMR spectrum matches the 
literature data.44 
N
O
O
F
3n  
2-(4-Fluorophenyl)isoindole-1,3-dione (3n).  This compound was obtained as a 
yellow  solid: mp 166-168 oC; IR (neat, cm-1) 1704, 1526, 1475, 1122, 1079, 831, 710; 
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HRMS m/z 241.05421 (calcd C14H8FNO2, 241.05391). The 1H and 13C NMR spectra match 
the literature data.45 
N
O
O
Br
3o  
2-(4-Bromophenyl)isoindole-1,3-dione (3o).  This compound was obtained as a light 
brown solid: mp 206-208 oC (lit.43 205-206 oC); 13C NMR (100 MHz, CDCl3) δ 121.9, 124.0, 
128.1, 130.8, 131.7, 132.4, 134.7, 167.0; IR (neat, cm-1) 1704, 1492, 1396, 1285, 1124, 818, 
714; HRMS m/z 300.97434 (calcd C14H8O2NBr, 300.97384). The 1H NMR spectrum 
matches the literature data.43 
N
O
O
I
3p  
2-(4-Iodophenyl)isoindole-1,3-dione (3p).  This compound was obtained as a white 
solid: mp 226-228 oC; 1H NMR (400 MHz, CDCl3) δ 7.21-7.26 (m, 2H), 7.79-7.84 (m, 4H), 
7.95-7.97 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 93.5, 124.0, 128.3, 131.6, 131.7, 134.7, 
138.4, 167.0; HRMS m/z 348.96046 (calcd C14H8O2NI, 348.95998). 
N
O
O
O
3q  
2-(3-Benzoylphenyl)isoindole-1,3-dione (3q).  This compound was obtained as a 
white solid: mp 179-181 oC; 1H NMR (400 MHz, CDCl3) δ 7.49-7.53 (m, 2H), 7.58-7.72 (m, 
3H), 7.79-7.81 (m, 2H), 7.85-7.90 (m, 4H), 7.95-7.97 (m, 2H); 13C NMR (100 MHz, CDCl3) 
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δ 124.1, 128.3, 128.6, 129.4, 129.6, 130.3, 130.4, 131.7, 131.9, 132.8, 134.8, 137.2, 138.5, 
167.1, 195.5; HRMS m/z 327.09008 (calcd C21H13O3N, 327.08954). 
CO2Me
NH
NO2
3r
 
Methyl 2-(4-nitrophenylamino)benzoate (3r).  This compound was obtained as a 
orange solid: mp 130-132 oC; 1H NMR (400 MHz, CDCl3) δ 3.92 (s, 3H), 6.96-6.99 (m, 1H), 
7.22-7.24 (m, 2H), 7.44-7.55 (m, 2H), 8.02 (d, J = 8.0 Hz, 1H), 8.16 (d, J = 9.0 Hz, 2H), 9.87 
(s, 1H); 13C NMR (100 MHz, CDCl3) δ 52.4, 115.6, 116.9, 117.6, 120.8, 126.0, 132.1, 134.3, 
141.5, 144.1, 147.9, 168.7; HRMS m/z 272.08005 (calcd C14H12O4N2, 272.07971). 
CO2Me
NH
CF3
3s
 
Methyl 2-(3-trifluoromethylphenylamino)benzoate (3s).  This compound was 
obtained as a yellow oil: 1H NMR (400 MHz, CDCl3) δ 3.89 (s, 3H), 6.78-6.82 (m, 1H), 
7.26-7.28 (m, 2H), 7.33-7.41 (m, 3H), 7.48 (s, 1H), 7.98 (d, J = 8.0 Hz, 1H), 9.61 (s, 1H); 13C 
NMR (100 MHz, CDCl3) δ 52.1, 113.1, 114.4, 118.1 (d, J = 3.7 Hz), 118.5, 119.7 (d, J = 3.7 
Hz), 122.8, 124.6 (d, J = 1.1 Hz), 125.5, 130.0, 131.9, 134.4, 141.8, 146.8, 169.0; IR (neat, 
cm-1) 3318, 2953, 1693, 1517, 1268, 1087; HRMS m/z 295.08234 (calcd C15H12O2NF3, 
295.08201). 
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CO2Me
NH
N
3t
 
 Methyl 2-(quinolin-5-ylamino)benzoate (3t).  This compound was obtained as a 
yellow solid: mp 92-94 oC; 1H NMR (400 MHz, CDCl3) δ 3.95 (s, 3H), 6.74-6.77 (m, 1H), 
6.94 (d, J = 8.5 Hz, 1H), 7.26 (t, J = 8.5 Hz, 1H), 7.39 (dd, J = 8.5, 4.1 Hz, 1H), 7.57 (d, J = 
7.4 Hz, 1H), 7.70 (t, J = 10.7 Hz, 1H), 7.95-8.03 (m, 2H), 8.42 (d, J = 8.8 Hz, 1H), 8.94 (d, J 
= 2.7 Hz, 1H), 9.86 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 52.1, 111.9, 114.3, 117.5, 120.9, 
121.2, 125.0, 126.4, 129.5, 131.5, 131.7, 134.5, 136.9, 149.0, 149.5, 150.8, 169.4; HRMS 
m/z 278.10611 (calcd C17H14O2N2, 278.10563). 
CO2Me
NH 3u
 
Methyl 2-(naphthalen-1-ylamino)benzoate (3u).  This compound was obtained as a 
white solid: mp 112-114 oC; 1H NMR (400 MHz, CDCl3) δ 3.91 (s, 3H), 6.74-6.77 (m, 1H), 
6.99 (d, J = 8.5 Hz, 1H), 7.25-7.29 (m, 1H), 7.48-7.57 (m, 4H), 7.74 (d, J = 8.0 Hz, 1H), 
7.91-7.93 (m, 1H), 8.05-8.07 (m, 1H), 8.15-8.17 (m, 1H), 9.82 (s, 1H); 13C NMR (100 MHz, 
CDCl3) δ 52.0, 111.5, 114.3, 116.8, 120.9, 122.8, 125.2, 125.9, 126.3, 126.4, 128.5, 129.8, 
131.6, 134.3, 134.8, 136.7, 149.5, 169.3; HRMS m/z 277.11069 (calcd C18H15O2N, 
277.11028). 
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CO2Me
NH
OMe
3v
MeO
 
Methyl 2-(2,6-dimethoxyphenylamino)benzoate (3v).  This compound was 
obtained as a pale yellow solid: mp 65-67 oC; 1H NMR (400 MHz, CDCl3) δ 3.75 (s, 3H), 
3.84 (s, 3H), 3.89 (s, 3H), 6.51 (dd, J = 8.8, 2.7 Hz, 1H), 6.75 (t, J = 7.4 Hz, 1H), 6.84 (d, J = 
8.7 Hz, 1H), 7.05 (d, J = 2.7 Hz, 1H), 7.31-7.35 (m, 1H), 7.41 (d, J = 8.4 Hz, 1H), 7.96 (d, J 
= 7.9 Hz, 1H), 9.50 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 52.0, 55.8, 56.5, 106.4, 106.7, 
111.9, 113.3, 114.9, 117.7, 131.2, 131.8, 134.0, 145.6, 146.7, 153.7, 168.7; IR (neat, cm-1) 
3323, 2947, 2833, 1692, 1524, 1455, 1262; HRMS m/z 287.11608 (calcd C16H17O4N, 
287.11576). 
CO2Me
NH
OMe3w
 
Methyl 2-(2-methoxyphenylamino)benzoate (3w).  This compound was obtained as 
a yellow oil: 1H NMR (400 MHz, CDCl3) δ 3.87-3.89 (m, 6H), 6.70-6.74 (m, 1H), 6.89-6.94 
(m, 2H), 7.00-7.04 (m, 1H), 7.31 (d, J = 3.4 Hz, 2H), 7.41-7.43 (m, 1H), 7.95 (d, J = 7.9 Hz, 
1H), 9.45 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 51.9, 55.9, 111.3, 112.8, 114.4, 117.3, 
120.6, 123.3, 130.2, 131.7, 134.0, 147.3, 151.5, 168.8; HRMS m/z 257.1040 (calcd 
C15H15O3N, 257.1052). 
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CO2Me
NH
Me3x
 
Methyl 2-(o-tolylamino)benzoate (3x).  This compound was obtained as a dark 
yellow solid: mp 54-56 oC; 1H NMR (400 MHz, CDCl3) δ 2.28 (s, 3H), 3.89 (s, 3H), 6.68 (t, 
J = 7.6 Hz, 1H), 6.91 (d, J = 8.4 Hz, 1H), 7.07 (t, J = 7.3 Hz, 1H), 7.18 (t, J = 7.7 Hz, 1H), 
7.22-7.27 (m, 2H), 7.32 (d, J = 7.6 Hz, 1H), 7.96 (dd, J = 8.0, 1.3 Hz, 1H), 9.28 (s, 1H); 13C 
NMR (100 MHz, CDCl3) δ 18.2, 51.9, 111.4, 113.9, 116.6, 124.0, 124.7, 126.7, 131.2, 131.7, 
132.9, 134.3, 139.1, 148.8, 169.2; HRMS m/z 241.1096 (calcd C15H15O2N, 241.1103). 
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CHAPTER 3. PALLADIUM-CATALYZED SYNTHESIS OF 9-
FLUORENYLIDENES AND 9,10-PHENANTHRENES THROUGH ARYNE 
ANNULATION 
 
Based on a paper to be published in the Journal of Organic Chemistry37 
Shilpa A. Worlikar and Richard C. Larock* 
Department of Chemistry, Iowa State University, Ames, Iowa 50011 
Abstract 
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 The palladium-catalyzed annulation of arynes by substituted ortho-halostyrenes and 
ortho-halo allylicbenzenes produces substituted 9-fluorenylidenes and 9,10-phenanthrenes 
respectively in good yields.  This methodology provides these important carbocyclic ring 
systems in a single step, which involves the generation of two new carbon-carbon bonds, 
occurs under relatively mild reaction conditions and tolerates a variety of functional groups, 
including cyano, ester, aldehyde and ketone groups. 
 
Introduction 
9-Fluorenylidenes and phenanthrenes are key structural units of many compounds 
possessing biological activity.  Derivatives of 9H-fluoren-9-ylidenes, commonly known as 9-
fluorenylidenes, are pharmaceutically and cosmetically significant.  The 9-fluorenylidene 
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derivative Paranylene is used in dispersible formulations of anti-inflammatory agents,1 while 
the 9-fluorenylidene derivative Lumefantrine is used in dermatological and photostable 
cosmetic compositions.2  3-Fluoren-9-ylidene-2'-hydroxy-3-phenylpropiophenone exhibits 
thermochromic properties.3  2,4,7-Trinitro-9-fluorenylmethacrylate (TNFMN) has been used 
to study the donor-acceptor interactions of poly(FIMA’s) with different tacticities.4  The 
phenanthrene derivative 3,7-dihydroxy-2,4,8-trimethoxyphenanthrene is known for its anti-
inflammatory properties,5 while the derivative Aristolochic acid exhibits tumor-inhibitory 
properties.6  The phenanthrene derivatives 3-hydroxy-2,4-dimethoxy-7,8-
methylenedioxyphenanthrene and 2,7-dihydroxy-1-methyl-5-vinylphenanthrene are 
cytotoxic.7 
Due to the pharmaceutical and biological importance of these compounds, the 
synthesis of  9-fluorenylidenes and phenanthrenes is important.  In the literature, 9-
fluorenylidenes are mainly synthesized, either from 9H-fluoren-9-one derivatives using a 
Wittig reaction8 or from 9H-fluorene derivatives.9  Several methods have been reported for 
the synthesis of 9-phenanthrene derivatives or 9,10-phenanthrene derivatives.  These 
approaches have several disadvantages, including the use of toxic chemicals, harsh reaction 
conditions or multistep reaction sequences.10  The synthesis of phenanthrenes by the 
cocyclization of arynes and alkynes is known,11 but in most cases the reactions are not 
regioselective.   
Transition metal-catalyzed annulation reactions are very valuable from a synthetic 
point of view.12  The Pd-catalyzed annulation of alkynes by substituted aryl and vinylic 
halides has been employed for the synthesis of a variety of carbocycles and heterocycles,13 
and some of these reactions have also been recently extended to arynes.  The major difficulty 
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in employing arynes is the high reactivity of arynes14 compared to alkynes, and the harsh 
reaction conditions often needed to generate arynes in situ.  A common problem associated 
with the high reactivity of arynes is their Pd-catalyzed cyclotrimerization15 to form 
polycyclic aromatic hydrocarbons.  Also, the harsh reaction conditions often required to 
obtain arynes severely limit the functional group compatibility of the chemistry.  It has been 
reported that the silylaryl triflate 2a in the presence of CsF generates benzyne under very 
mild reaction conditions.16  This method of aryne generation has been used in our research 
laboratories and reported in the literature for a variety of electrophilic and nucleophilic 
reactions,17 Pd-catalyzed annulation reactions,18 cycloaddition reactions19 and insertion 
reactions.20   
We have previously reported palladium-catalyzed alkyne annulations of ethyl (E)-4-
(2-iodophenyl)-2-butenoate to obtain naphthalenes,21 while the palladium-catalyzed alkyne 
annulation of methyl 3-(2-iodophenyl)acrylate has also been reported in the literature.22  To 
the best of our knowledge, the palladium-catalyzed aryne insertion and subsequent 
cyclization of ortho-halostyrenes or ortho-halo allylicbenzenes, has not been reported 
previously.  We report herein an efficient approach to 9-fluorenylidenes and phenanthrenes, 
which proceeds in good yields from starting materials that are readily available or easy to 
synthesize, and involves a palladium-catalyzed annulation of arynes. 
     
Results and Discussion 
The focus of our early studies on this project was the palladium-catalyzed aryne 
annulation of  substituted ortho-halostyrenes to give substituted 9-fluorenylidenes in good 
yields.  (E)-3-(2-Iodophenyl)acrylonitrile (1a) was used as a model system for optimization 
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of the reaction conditions using 2-(trimethylsilyl)phenyl trifluoromethanesulfonate (2a) as 
the aryne precursor.  Early in this work, the reaction was run with 0.3 mmol of 1a, 2.0 equiv 
of 2a, 5 mol % Pd(dba)2, 5 mol % P(o-tolyl)3, and 3 equiv of CsF as the base in 5 ml of 1:9 
acetonitrile/toluene at 110 oC in a sealed vial to obtain a 28% isolated yield of the desired 2-
(9H-fluoren-9-ylidene)acetonitrile (3a) (eq 1; Table 1, entry 1).  Previously in our  
 
I
CN TMS
OTf
CN
solvent
+
Pd catalyst
phosphine ligand (1)
1a 2a 3a
CsF
  
 
Table 1. Optimization of the Palladium-Catalyzed Benzyne Insertion into (E)-3-(2-
Iodophenyl)acrylonitrile Using Various Solvents and Ligands (eq. 1)a 
entry  Pd(dba)2  phosphine ligand                                                       solvent     % yieldb 
           mol %      (mol %)                                                     (CH3CN:PhCH3) 
1 5 P(o-tolyl)3 (5) 1:9 28c 
2 5 P(o-tolyl)3 (5) 1:7 36c 
3 5 P(o-tolyl)3 (5) 1:5 35c 
4 5 P(o-tolyl)3 (5) 1:3 35c 
5 5 P(o-tolyl)3 (5) 1:1 37c 
6 5 P(o-tolyl)3 (5) 1:0 25c 
7 5 P(o-tolyl)3 (5) 0:1 0c 
8 10 P(o-tolyl)3 (10) 1:1 39c 
9 10 P(o-tolyl)3 (20) 1:1 49c 
10 15 P(o-tolyl)3 (30) 1:1 48c 
11 20           - 1:1 0c 
12 10 Tris(2,4,6-trimethoxyphenyl)phosphine (20) 1:1 40c 
13 10 Tris(2,6-dimethoxyphenyl)phosphine (20) 1:1 75 
14 10 Tri(2-methoxyphenyl)phosphine (20) 1:1 84 
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Table 1. Continued 
entry  Pd(dba)2  phosphine ligand                                                       solvent     % yieldb 
           mol %      (mol %)                                                     (CH3CN:PhCH3) 
15 10 Tri-(2-furyl)phosphine (20) 1:1 30 
16 10 [(CH3)3P·AgI]4 (20) 1:1 25c 
17 10 Tri(t-butyl)phosphine (20) 1:1 <5c,d 
18 10 2-(Di-tert-butylphosphino)biphenyl (20) 1:1 32 
19 10 4,5-Bis(diphenylphosphino)-9,9-dimethylxanthene 
(Xantphos) (20) 
1:1 35 
20 10 1,3-Bis(diphenylphosphino)propane (dppp) (20) 1:1 <5c,d 
21 10 1,1′-Bis(diphenylphosphino)ferrocene (dppf) (20) 1:1 <5d 
22 10 1,1-Bis(diphenylphosphino)methane (dppm) (20) 1:1 91 
a Representative procedure:  (E)-3-(2-iodophenyl)acrylonitrile (0.3 mmol), 2-(trimethylsilyl)phenyl 
trifluoromethanesulfonate (2.0 equiv), Pd(dba)2, ligand, CsF (3 equiv) and solvent (5 mL) were placed in 
a 4 dram vial.  The vial was sealed with a screw cap.  The reaction was then stirred at 110 oC for 24 h.  b 
Isolated yields.  c Some starting material 1a was left.  d GC yields. 
 
laboratories, we have found that the polarity of the acetonitrile/toluene solvent system, 
greatly affects the yields of the products of the aryne chemistry under our experimental 
conditions, as it controls the rate of aryne formation.  An increase in the polarity of the 
solvent system only slightly increases the yield of the desired product 3a (entries 2-5).  When 
the reaction was run in pure acetonitrile, the yield dropped to 25% (entry 6) with a 
simultaneous increase in the amount of the triphenylene side product resulting from 
palladium-catalyzed cyclotrimerization of the benzyne.  None of the desired product was 
obtained when pure toluene was used as the solvent for the reaction, and both the starting 
ortho-halostyrene 1a and the benzyne precursor 2a remained unreacted under those 
conditions (entry 7).  We believe that, this is due to the low solubility of the fluoride source 
in toluene, which hinders formation of the benzyne.  With 1:1 acetonitrile/toluene as the 
optimized solvent system for the reaction, we tried to improve the yield of the desired 
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product 3a by increasing the amount of the Pd(dba)2 catalyst to 10 mol % and the P(o-tolyl)3 
ligand to 10 mol %.  There was only a slight increase in the yield of the desired product 3a to 
39% (entry 8).  An increase in the P(o-tolyl)3 ligand to 20 mol % further increased the yield 
to 49% (entry 9).  While maintaining a 1:2 ratio of the Pd(dba)2  to the P(o-tolyl)3, but further 
increasing the amount of the catalyst and the ligand, no significant increase in the yield was 
observed (entry 10).  The reaction in the absence of P(o-tolyl)3 did not yield the desired 
product 3a (entry 11). 
Noting the importance of the ligand in the reaction, various ligands have been 
screened with the aim of increasing the yield of the 9-fluorenylidene 3a.  Electron-rich 
tris(2,4,6-trimethoxyphenyl)phosphine gave a reduced yield of 40% (entry 12), while 
tris(2,6-dimethoxyphenyl)phosphine increased the yield to 75% (entry 13).  Relatively 
unhindered tri(2-methoxyphenyl)phosphine improved the yield still further to 84% (entry 
14).  Along with steric factors, the electronic nature of the phosphine ligand seems to have an 
effect on the overall yield of the desired product 3a (compare entries 12-14).  To further 
study the effect on the yield of the desired product, in the presence of an oxygen moiety in 
the phosphine ligand (compare entries 9 and 14), the reaction was carried out with tri(2-
furyl)phosphine ligand, which gave a poor 30% yield of 3a (entry 15).  The ligand 
trimethylphosphine obtained from [(CH3)3P·AgI]4 gave a poor 25% yield of the desired 
product 3a (entry 16).  The bulkier phosphine ligand tri(t-butyl)phosphine gave an extremely 
poor yield (<5%), while 2-(di-tert-butylphosphino)biphenyl gave only a 32% yield of the 
fluorenylidene (entries 17 and 18).  We have also screened bidentate ligands with a view 
towards improving the yield of the desired 9-fluorenylidene 3a.  The bidentate Xantphos 
ligand did not improve the yield of the reaction (entry 19), affording only a 35% yield of 3a.  
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The phosphine ligands dppp and dppf gave extremely poor yields (entries 20 and 21), but to 
our surprise dppm improved the yield to 91% (entry 22). 
With dppm as the apparent ligand of choice, the reaction has been carried out at a 
lower temperature.  At 85 oC, the desired product 3a was obtained in a lower 52% yield 
(Table 2, entry 1), and the reaction did not go to completion.  When the reaction was run at 
100 oC, the yield increased to 68% (entry 2), while a further increase in the temperature to 
120 oC did not have much effect on the yield of the product (compare Table 1, entry 22 and 
Table 2, entry 3).  Reducing the amount of the benzyne precursor to 1.5 equiv did not effect 
the yield of the desired product 3a (entry 4), but a further reduction of 2a to 1.2 equiv 
decreased the yield of 3a to 69% (entry 5).  Either a decrease or an increase in the amount of 
the base CsF gave reduced yields of 78% and 86% respectively (compare entries 4, 6 and 7).     
 
Table 2. Optimization of the Palladium-Catalyzed Benzyne Insertion into (E)-3-(2-
Iodophenyl)acrylonitrile with dppm as the Ligand (eq. 1)a 
entry Pd(dba)2 
(mol %) 
dppm 
(mol %) 
precursor 
(equiv) 
CsF time 
(h) 
temp. 
(oC) 
% yieldb 
3a 
1 10 20 2.0 3 24 85 52c 
2 10 20 2.0 3 24 100 68c 
3 10 20 2.0 3 24 120 92 
4 10 20 1.5 3 24 110 91 
5 10 20 1.2 3 24 110 69c 
6 10 20 1.5 2 24 110 78 
7 10 20 1.5 5 24 110 86 
8 5 5 1.5 3 24 110 49c 
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Table 2. Continued 
entry Pd(dba)2 
(mol %) 
dppm 
(mol %) 
precursor 
(equiv) 
CsF time 
(h) 
temp. 
(oC) 
% yieldb 
3a 
9 5 10 1.5 3 24 110 62c 
10 10 10 1.5 3 24 110 69c 
11 20 10 1.5 3 24 110 42 
12 10 40 1.5 3 24 110 76 
13 10 20 1.5 3 12 110 71c,d 
a Representative procedure:  (E)-3-(2-iodophenyl)acrylonitrile (0.3 mmol), 2-(trimethylsilyl)phenyl 
trifluoromethanesulfonate, Pd(dba)2, dppm, CsF and solvent (5 mL) were placed in a 4 dram vial.  The 
vial was sealed with a screw cap.  The reaction was then stirred at the desired temperature for the 
indicated time. b Isolated yields.  c Some starting material 1a was left.  d GC yields. 
 
This variation in yields probably reflects a variation in the rate of benzyne formation from 
the 2-(trimethylsilyl)phenyl trifluoromethanesulfonate.  After optimization of the reaction 
conditions with respect to the solvent system, the phosphine ligand, the temperature, the 
amount of the aryne precursor and the base, we also studied if the reaction can be carried out 
at a lower catalyst loading with different palladium catalyst to phosphine ligand ratios.  
When the reaction was run with only 5 mol % of the Pd(dba)2 catalyst and 5 mol % of the 
dppm ligand, the yield decreased to 49% (entry 8).  An increase in the amount of the dppm 
ligand to 10 mol % increased the yield to 62% (entry 9), indicating that a ratio of Pd(dba)2 to 
the dppm ligand of 1:2 works better than the ratio of 1:1, even at a lower catalyst loading.  To 
cross check this finding, the reaction was carried out with 10 mol % of Pd(dba)2 and 10 mol 
% of the dppm ligand which, afforded only a 69% yield of the desired product 3a (compare 
entries 4 and 10).  A higher Pd(dba)2 to dppm ligand ratio or a further excess of the dppm 
ligand decreased the yield of 3a to 42% and 76% respectively (entries 11 and 12).  A reduced 
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reaction time gave a lower yield of 71% (entry 13).  Thus, our optimized conditions for the 
palladium-catalyzed aryne annulation are 0.3 mmol of 1a, 1.5 equiv of 2a, 10 mol % of 
Pd(dba)2, 20 mol % of dppm, 3 equiv of CsF in 5 ml of 1:1 acetonitrile/toluene at 110 oC in a 
sealed vial for 24 h. 
After obtaining our best reaction conditions for the aryne annulation, we examined 
the scope of this reaction on various substrates.  Aryl halides 1f, 1i, 1j, and 1k were prepared 
by standard Wittig chemistry (Scheme 1), using commercially available aldehydes 4a, 4b and 
4d, while 4c was prepared according to a literature procedure.23  The aryl halide 1t was 
prepared by condensation of o-iodobenzaldehyde with diethyl malonate (Scheme 2).  Aryl 
halides 1a, 1h, and 1r were obtained from commercial sources, while 1b,24 1c,24 1d,25 1e,26 
1g,27 1l,28 1m,28 1n,21 1o,28 1p,28 1q,29 and 1s30  were prepared according to literature 
procedures.  The benzyne precursor 2a is commercially available, while the aryne precursors 
2b,19 2c,19 2d19 and 2e19 have been prepared according to literature procedures.    
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The model system 1a under our optimized conditions with 2-(trimethylsilyl)phenyl 
trifluoromethanesulfonate (2a) as the benzyne precursor gave an 91% isolated yield of the 
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Scheme 2 
CHO
I I
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15 mol % piperidine
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toluene, reflux, 5 h
1t62 %  
 
desired product 3a (Table 3, entry 1).  Compound 3a was obtained in a slightly lower 79% 
yield, when the reaction was carried out using the corresponding aryl bromide, (E)-3-(2-
bromophenyl)acrylonitrile (1b).  The improved yield from the aryl iodide is no doubt a direct  
 
Table 3. Synthesis of 9-Fluorenylidenes and Phenanthrenes by Palladium-Catalyzed Aryne 
Annulation of ortho-Halostyrenes and ortho-Halo Allylicbenzenes.a 
entry unsaturated arene benzyne 
precursor 
product(s) % 
isolated 
yield 
1 
CN
I1a  
TMS
TfO
2a  3a
CN
 
91  
2 
Br
CN
1b  
2a 
 
 
3a 79  
3 
Br
CN
1c  
2a 3a 72  
4 
I
CO2Me
1d  
2a 
3b
CO2Me
 
76  
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Table 3. Continued 
entry unsaturated arene benzyne 
precursor 
product(s) % 
isolated 
yield 
5 
Br
CO2Et
1e  
2a 
3c
CO2Et
 
75  
6 
I
H
O
1f  
2a 
3d
CHO
 
76  
7 
I
Ph
O
1g  
2a 
3e
C(O)Ph
 
61  
8 
I
NO2
1h  
2a 
3f
NO2
 
0 
9 
Br
CO2EtMeO
MeO 1i
2a MeO
MeO 3g + 3h
CO2Et
 
<5%b 
 
10 
CN
I
O
O 1j  
2a O
O 3i
CN
 
73c 
11 
CN
I
F
1k  
2a 
F
3j
CN
 
46d,e 
 
12 1a 
TMS
TfO 2b  
3k + 3l
CN
 
82f 
[11:1] 
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Table 3. Continued 
entry unsaturated arene benzyne 
precursor 
product(s) % 
isolated 
yield 
13 1a 
TMS
TfO
OMe
OMe
2c
OMe
OMe3m + 3n
CN
 
78f 
[4:1] 
14 
I
CO2Et
1l  
2a 
CO2Et
3o
 
62 
15 
Br
CO2Et
1m  
2a 3o 49 
16 1l 2c 
CO2Et
OMe
OMe
3p
 
45 
17 
I
CO2Et
Ph
1n  
2a 
CO2EtPh
3q  
~20b 
18 
I
CN
1o  
2a 
CN
3r
 
58 
19 
I
CN
1p
 
2a 3r 47 
20 1o 2b 
CN
3s
 
52 
21 1o 
TMS
TfO
Me
Me2d  
CN
Me
Me
3t
 
50 
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Table 3. Continued 
entry unsaturated arene benzyne 
precursor 
product(s) % 
isolated 
yield 
22 1o 
TMS
TfO
F
F
2e  
CN
F
F
3u
 
0 
23 
I
Ph
1q  
2a 
Ph
3v  
35b 
 
     
a Representative procedure:  aryl halide 1(a-r) (0.3 mmol), silylaryl triflate 2(a-e) (2.0 equiv), 10 mol % of 
Pd(dba)2, 20 mol % of dppm, CsF (3 equiv) and 1:1 CH3CN/PhCH3 (5 mL) were placed in a 4 dram vial.  The 
vial was sealed with a screw cap.  The reaction was then stirred at 110 oC for 24 h.  b GC yields.  c Eight percent 
of a minor isomer is observed by GC analysis.  d Some starting material 1l was left.  The reaction did not go to 
completion even at 140 oC.  e Five percent of a minor isomer is observed by GC analysis.  f The ratio was 
determined by H1 NMR spectroscopy.   
 
result of the more facile oxidative addition of aryl iodides over aryl bromides.  The cis 
isomer (Z)-3-(2-bromophenyl)acrylonitrile (1c) gave a slightly lower yield of 72% than the  
corresponding trans isomer, (E) 3-(2-bromophenyl)acrylonitrile (1b) (compare entries 2 and 
3).  With a methyl ester as the electron-withdrawing group (EWG) on the double bond of the 
ortho-halostyrene 1d, the yield dropped to 76% under our optimized conditions (compare 
entries 1 and 4).  Similar results were obtained using the corresponding bromide-containing 
ethyl ester (entry 5).  With an aldehyde as the EWG on the ortho-halostyrene 1f, a 76% yield 
of the desired product 3d was obtained (entry 6).  The yield is comparable to that obtained 
with an ester group present on the double bond of the ortho-halostyrene.  With a ketone 
present in the ortho-halostyrene 1g, the yield dropped to 61% (entry 7).  Previously aryl 
triflates have proved to work well in oxidative palladium insertion chemistry.  Thus, we 
carried out a reaction with 2-(3-oxo-3-phenyl-propenyl)phenyl trifluoromethanesulfonate, but 
 
83
none of the desired product was obtained.  When a stronger electron-withdrawing nitro group 
was placed on the ortho-halostyrene, the reaction also failed to give the desired product 3f 
(entry 8).  Instead, we got a polymeric residue in the reaction flask.  We believe 2-(2-
nitrovinyl)iodobenzene (1h) undergoes polymerization under our reaction conditions.  Also, 
when an electron-donating methyl group was placed on the double bond of the ortho-
halostyrene, as in 1-iodo-2-(1-propenyl)benzene, the reaction with 2-(trimethylsilyl)phenyl 
trifluoromethanesulfonate (2a)  failed to give the desired fluorenylidene under our reaction 
conditions.  When electron-donating methoxy groups were placed on the ortho-halostyrene, 
we obtained an extremely poor yield (<5%), presumably because oxidative addition of 
palladium is unfavorable in such electron-rich aryl halides (compare entries 5 and 9).  On the 
other hand, the electron-rich substrate 1j with a carbon-iodine, instead of a carbon-bromine 
bond, gave the desired product in a 73% yield (entry 10).  The ortho-halostyrene 1k, reacted 
with 2a to give a 46% yield of the fluorenylidene (entry 11).  However, the reaction was slow 
and did not go to completion even at the higher temperature of 140 oC.  The structure of the 
major product has not been rigorously established, but is assumed to be the less hindered E-
isomer.  Five percent of a minor isomer has also been observed. 
We have also studied the scope of the reaction using various aryne precursors.  The 
model system 1a on reaction with the aryne precursor 2b gave the desired compounds 3k and 
3l as a 13:1 mixture of inseparable isomers in an 82% overall yield (entry 12).  It is unclear 
as to which stereoisomer is the major product.  The aryne precursor 2c with two electron-rich 
methoxy groups gave a slightly lower yield of 78% when allowed to react with the model 
system 1a; a 4:1 ratio of stereoisomers was obtained (entry 13).  Again, the stereochemistry 
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of the major isomer is unknown.  The slightly lower yield may be due to the slower rate of 
aryne formation from precursor 2c, as observed previously by us.   
When we carried out the palladium-catalyzed aryne annulation using aryne precursor 
2-(trimethylsilyl)phenyl trifluoromethanesulfonate (2a) and ortho-halostyrene 1r, bearing a 
trisubstituted double bond, under our optimized reaction conditions, the reaction was messy 
and the desired product 3w was obtained in an extremely low (<5%) yield as determined by 
GC analysis (Scheme 3).  We have also tried an analogous reaction with ortho-halostyrene 
1s, where the electron-withdrawing groups on the double bond of the styrene were ester 
groups, instead of cyano groups.  The desired product 3x was obtained in a low (<5%) yield 
as determined by GC analysis.  A reaction with the corresponding aryl iodide 1t only slightly 
improved the yield to ~5-10% and the reaction was cleaner when compared to that of aryl 
bromide 1s. 
Scheme 3 
R1
R2
X
TMS
TfO
R1 R2
1:9 CH3CN/PhCH3
110  oC, 24 h
10 mol %  Pd(dba)2
20 mol %  dppm
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2a1r (X = Br; R1,R2 = CN)
1s (X = Br; R1,R2 = CO2Et)
1t (X = I; R1,R2 = CO2Et)
3w (R1,R2 = CN), <5%
3x (R1,R2 = CO2Et),<10%
 
 
We have also been able to extend our methodology to the synthesis of phenanthrene 
derivatives from the corresponding ortho-halo allylicbenzenes.  Ethyl (E)-4-(2-
iodophenyl)but-2-enoate (1l) on reaction with 2a gave a 62% yield of the desired 9-
phenanthrene 3o (entry 14).  Ethyl (E)-4-(2-bromophenyl)but-2-enoate (1m) gave a slightly 
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lower yield of 49% of 3o, presumably due to reasons mentioned previously.  Ethyl (E)-4-(2-
iodophenyl)but-2-enoate, when allowed to react with the electron-rich aryne precursor 2c, 
gave a somewhat lower yield of 45% of the desired phenanthrene 3p (compare entries 14 and 
16). The ortho-halo allylicbenzene 1n gave a poor ~20% yield of the desired phenanthrene 
3q, but the product could not be purified (entry 17).  An electron-withdrawing cyano group 
on the ortho-halo allylicbenzene 1o, instead of an ester group, gave a slightly lower 58% 
yield of the desired phenanthrene 3r, contrary to our observations with the analogous 
fluorenylidenes (compare entries 14 and 18, and entries 1 and 4).  (Z)-4-(2-Iodophenyl)-2-
butenenitrile (1p) gave a 47% yield of the desired phenanthrene, which was slightly less than 
the (E)-isomer (compare entries 18 and 19).  ortho-Halo allylicbenzene 1o, when treated with 
the aryne precursors 2b and 2d, gave 52% and 50% yields respectively of the corresponding 
phenanthrenes 3s and 3t (entries 20 and 21).  Thus, the yield of the reaction decreases when 
more electron-rich aryne precursors are used.  When inductively electron-withdrawing 
fluorine atoms were placed on the aryne precursor 2e, none of the desired product was 
obtained for reasons not known to us.  The ortho-halostyrene 1q gave the phenanthrene 3v in 
a 35% yield.  This product, however, could not be isolated from the corresponding 
triphenylene, which is the major side product in all of these reactions.      
We propose the following possible mechanisms for these reactions based on the 
known reactions of organopalladium compounds with alkynes (Scheme 4).13  The reaction 
can follow two pathways, path a or path b.  In path a, the aryne generated from the triflate in 
the presence of the fluoride source coordinates with Pd(0), affording palladacycle I.31  
Oxidative addition of the aryl halide to I might generate an arylpalladium(IV) complex II.  
Upon reductive elimination, complex II could afford a new arylpalladium intermediate III.   
 
86
Scheme 4 
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Alternatively, according to path b, Pd(0) might add oxidatively to the aryl halide to afford the 
arylpalladium(II) intermediate IV, which in turn might add to the aryne32 to afford 
arylpalladium intermediate III.  Regardless of how intermediate III is generated, the 
palladium-carbon bond in this intermediate can then add across the neighboring carbon-
carbon double bond to afford intermediate V, which directly affords the fluorenylidene 
product by β-hydride elimination when n = 0.  When n = 1, the phenanthrene is obtained by 
further isomerization of the resulting olefin.  This isomerization may be promoted by the 
base present in the reaction or by the palladium hydride generated during the process.  
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Similar intramolecular palladium-catalyzed Heck reactions, followed by olefin isomerization, 
have been reported by us during the carbopalladation of alkynes to generate naphthalenes.21 
 
Conclusions 
A range of fluorenylidenes and phenanthrenes have been obtained from simple 
starting materials that are readily available or easily synthesized, using a one step palladium-
catalyzed aryne insertion of o-halostyrenes and o-halo allylbenzenes respectively.  The 
arynes are obtained in situ under mild reaction conditions from the corresponding 2-
(trimethylsilyl)aryl trifluoromethanesulfonates and CsF.  Our methodology is tolerant of a 
variety of functional groups, including cyano, ester, aldehyde, ketone, and methoxy groups, 
which provide a handle for further organic transformations.  A fluorine moiety can also be 
introduced into the products.  This methodology provides a very convenient, general 
approach to these two important classes of aromatic hydrocarbons.  
 
Experimental Section  
General.  The 1H and 13C NMR spectra were recorded at 300 and 75.5 MHz or 400 
and 100 MHz respectively.  Thin layer chromatography was performed using 60 mesh silica 
gel plates, and visualization was effected with short wavelength UV light (254 nm).  All 
melting points are uncorrected.  All high resolution mass spectra were recorded using EI at 
70 eV.  All reagents were used directly as obtained commercially unless otherwise noted.   
 
General procedure for the synthesis of the starting ortho-halostyrenes by a 
Wittig reaction.  To a solution of triphenylphosphoranylidene (4.5 mmol) in 30 ml of 
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CH2Cl2 was added dropwise a solution of the aldehyde (3.0 mmol) in 6 ml of CH2Cl2 at 0 oC 
under an inert argon atmosphere.  The resulting mixture was stirred at 25 oC until completion 
of the reaction, which was monitored by TLC.  The solvent was then evaporated under 
reduced pressure.  The solid residue was dissolved in 15 ml of hexanes and the mixture was 
stirred at 25 oC for 30 min.  The Ph3PO was filtered off and the solvent was removed under 
reduced pressure.  The residue was purified by flash chromatography on silica gel using 
hexanes/ EtOAc as the eluent to afford the desired product.  
CHO
I1f  
(E)-3-(2-Iodophenyl)propenal (1f).  This compound was obtained as a yellow solid: 
mp 79-80 °C (lit.33 78-79 °C); 1H NMR (400 MHz, CDCl3) δ 6.56-6.62 (m, 1H), 7.07-7.11 
(m, 1H), 7.39 (t, J = 7.6 Hz, 1H), 7.60 (dd, J = 7.9, 1.5 Hz, 1H), 7.71 (d, J = 15.7 Hz, 1H), 
7.92 (dd, J = 7.9, 0.9 Hz, 1H), 9.76 (d, J = 7.7 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 
102.0, 127.7, 128.8, 130.8, 132.2, 136.9, 140.3, 155.4, 193.4. 
CO2Et
Br1i
MeO
MeO
 
(E)-Ethyl 3-(2-bromo-4,5-dimethoxyphenyl)propenoate (1i).  This compound was 
obtained as a white solid: mp 112-114 °C; 1H NMR (400 MHz, CDCl3) δ 1.34 (t, J = 7.2 Hz, 
3H), 3.89 (s, 6H), 4.27 (q, J = 7.1 Hz, 2H), 6.28 (d, J = 15.8 Hz, 1H), 7.04 (d, J = 13.7 Hz, 
2H), 7.96 (d, J = 15.9 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 14.3, 56.0, 56.2, 60.5, 109.0, 
115.4, 117.1, 118.5, 126.2, 142.6, 148.5, 151.2, 166.5; HRMS m/z 314.01596 (calcd 
C13H15BrO4, 314.01537). 
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CN
I1j
O
O
 
3-(6-Iodobenzo[1,3]dioxol-5-yl)acrylonitrile (1j).  This compound was obtained as 
a white solid: mp 104-106 °C; 1H NMR (400 MHz, CDCl3) δ 5.35 (d, J = 11.8 Hz, 1H), 5.97 
(s, 2H), 7.18 (d, J = 11.9 Hz, 1H), 7.26 (s, 1H), 7.48 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 
91.0, 96.4, 97.1, 102.5, 105.8, 108.6, 116.8, 119.2, 152.2, 153.5; HRMS m/z 298.94482 
(calcd C10H6INO2, 298.94433). 
CN
I1k
F
 
3-(2-Fluoro-6-iodophenyl)acrylonitrile (1k).  This compound was obtained as a 
white solid: mp 82-83 °C; 1H NMR (400 MHz, CDCl3) δ 6.12 (d, J = 16.8 Hz, 1H), 7.03-7.16 
(m, 2H), 7.41 (d, J = 16.8 Hz, 1H), 7.75 (d, J = 7.7 Hz, 1H); 13C NMR (100 MHz, CDCl3) 
101.64, 101.66, 104.0, 104.2, 115.4, 116.8, 117.0, 117.8, 124.9, 125.0, 132.70, 132.79, 
136.35, 136.39, 148.54, 148.57, 159.6, 162.1 (extra peaks due to splitting by fluorine); 
HRMS m/z 272.94554 (calcd C9H5FIN, 272.94508). 
I
CO2Et
CO2Et
1t  
Diethyl [(2-iodophenyl)methylene]propanedioate (1t).  This compound was 
prepared by the following procedure.  To a solution of 2-iodobenzaldehyde (10 mmol), 
diethyl malonate (10 mmol), and piperidine (1.5 mmol) in 60 mL of toluene, benzoic acid 
(1.0 mmol) was added.  The reaction mixture was refluxed for 5 h using a Dean-Stark 
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condenser for water removal.  The mixture was cooled to room temperature and diluted with 
diethyl ether (100 mL) and EtOAc (100 mL).  The organic layer was separated and washed 
two times each with 2 N HCl, saturated NaHCO3, and brine.  The organic layer was then 
dried over MgSO4 and the solvent evaporated under reduced pressure.  The residue was 
purified by flash chromatography on silica gel using hexanes/ EtOAc as the eluent and 
further subjected to distillation to remove traces of diethyl malonate (bp: 195-196 oC) at ~200 
oC to afford the desired product as a brown oil:  1H NMR (400 MHz, CDCl3) δ 1.14 (t, J = 
7.0 Hz, 3H), 1.34 (t, J = 7.1 Hz, 3H), 4.19 (q, J = 7.2 Hz, 2H), 4.33 (q, J = 7.0 Hz, 2H), 7.03-
7.07 (m, 1H), 7.29-7.39 (m, 2H), 7.83 (s, 1H), 7.89 (d, J = 7.9 Hz, 1H); 13C NMR (100 MHz, 
CDCl3) δ 13.9, 14.2, 61.6, 61.8, 99.6, 128.2, 128.6, 128.9, 131.1, 137.4, 139.4, 145.9, 163.5, 
165.4; IR (neat, cm-1) 3060, 2979, 1746, 1627, 1458, 1361; HRMS m/z 374.00220 (calcd 
C14H15IO4, 374.00151). 
 
General procedure for the palladium-catalyzed annulation of arynes by ortho-
halostyrenes and ortho-halo allylicbenzenes.  To 0.3 mmol of the aryl halide was added the 
o-silylaryl triflate (1.5 equiv), Pd(dba)2 (10 mol %), dppm (20 mol %) and 1:1 
CH3CN/PhCH3 (5 ml).  CsF (3.0 equiv) was then added and the vial was sealed with a screw 
cap.  The reaction mixture was then stirred at 110 oC for 24 h.  After the reaction was 
complete, the resulting solution was washed with brine (25 mL) and extracted with EtOAc 
(25 mL). The combined EtOAc fractions were dried over Na2SO4 and concentrated under 
reduced pressure. The residue was purified by flash chromatography on silica gel using 
hexanes/ EtOAc as the eluent to afford the desired product.  
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3a
CN
 
2-(9H-Fluoren-9-ylidene)acetonitrile (3a).  This compound was obtained as a 
yellow solid: mp 109-111 oC (lit.34 109-110 oC); 13C NMR (100 MHz, CDCl3) δ 88.6, 120.3, 
120.4, 121.7, 125.5, 128.0, 128.5, 131.9, 132; HRMS m/z 203.07381 (calcd C15H9N, 
203.07350). The 1H NMR spectrum matches the literature data.34 
3b
CO2Me
 
Methyl 2-(9H-fluoren-9-ylidene)acetate (3b).  This compound was obtained as a 
white solid: mp 60-62 oC (lit.35 59-62 oC); HRMS m/z 236.08397 (calcd C16H12O2, 
236.08373). The 1H and 13C NMR spectra match the literature data.35  
3c
CO2Et
 
Ethyl 2-(9H-fluoren-9-ylidene)acetate (3c).  This compound was obtained as a 
yellow solid: mp 75-76 oC; 13C NMR (100 MHz, CDCl3) δ 14.5, 60.9, 114.1, 119.7, 119.9, 
121.4, 127.6, 128.2, 129.3, 130.7, 131.0, 135.3, 139.0, 140.9, 142.6, 148.4, 166.5. The 1H 
NMR spectrum matches the literature data.36 
3d
CHO
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2-(9H-Fluoren-9-ylidene)acetaldehyde (3d).  This compound was obtained as a 
yellow solid: mp 115-117 oC (lit.9a 115.6-116.3 oC). The 1H and 13C NMR spectra match the 
literature data.36 
3e
C(O)Ph
 
2-(9H-Fluoren-9-ylidene)-1-phenylethanone (3e).  This compound was obtained as 
a yellow solid: mp 130-132 oC; 1H NMR (400 MHz, CDCl3) δ 7.19-7.24 (m, 1H), 7.29 (dt, J 
= 7.5, 0.8 Hz, 1H), 7.34-7.42 (m, 2H), 7.48-7.52 (m, 2H), 7.58-7.63 (m, 4H), 7.76 (d, J = 7.6 
Hz, 1H), 8.09-8.11 (m, 2H), 8.33 (d, J = 7.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 119.6, 
119.8, 120.0, 121.2, 127.6, 127.7, 128.1, 128.94, 128.98, 130.6, 130.9, 133.5, 135.5, 138.4, 
138.9, 141.0, 142.4, 146.2, 192.6 ; HRMS m/z 282.10477 (calcd C21H14O, 282.10447). 
O
O 3i
CN
 
(1,3-Dioxacyclopenta[b]fluoren-9-ylidene)acetonitrile (3i).  This compound was 
obtained as a pale yellow solid: mp 193-195 oC; 1H NMR (400 MHz, CDCl3) δ 6.17 (s, 2H), 
7.24-7.25 (m, 1H, merged CDCl3 peak shows extra proton), 7.67-7.73 (m, 2H), 8.00 (s, 1H), 
8.10 (s, 1H), 8.25-8.27 (m, 1H), 8.47-8.50 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 101.2, 
102.2, 106.4, 107.5, 118.4, 123.0, 126.2, 126.5, 127.5, 127.9, 128.8, 129.2, 129.9, 134.7, 
148.5, 150.9; HRMS m/z 247.0633 (calcd C16H9NO2, 247.0633). 
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F
3j
CN
 
(1-Fluorofluoren-9-ylidene)acetonitrile (3j).  This compound was obtained as a 
yellow solid: mp 129-131 oC; 1H NMR (400 MHz, CDCl3) δ 6.44 (d, J = 3.4 Hz, 1H), 6.95-
7.00 (m, 1H), 7.36-7.49 (m, 4H), 7.64 (d, J = 7.4 Hz, 1H), 8.43 (d, J = 7.6 Hz, 1H); 13C NMR 
(100 MHz, CDCl3) δ 93.6, 93.7, 115.6, 115.8, 116.4, 116.5, 117.5, 120.7, 125.5, 129.1, 
131.8, 133.3, 133.4, 135.1, 141.23, 141.26, 143.3, 143.4, 150.8, 159.5, 162.0 (extra peaks 
due to fluorine splitting); HRMS m/z 221.0634 (calcd C15H8FN, 221.0641). 
3k + 3l
CN
 
(2,3-Dihydro-1H-cyclopenta[b]fluoren-9-ylidene)acetonitriles (3k + 3l).  These 
compounds were obtained as a yellow oil as a 11:1 mixture: 1H NMR (400 MHz, CDCl3) δ 
2.08-2.24 (m, 6H), 2.88-3.04 (m, 11H), 3.13-3.18 (m, 1H), 7.09-7.29 (m, 4H), 7.38-7.42 (m, 
6H), 7.50-7.89 (m, 5H), 8.10-8.64 (m, 3H); 13C NMR (75 MHz, CDCl3) δ 25.7, 32.8, 32.9, 
33.2, 33.3, 87.1, 87.2, 116.4, 117.7, 117.9, 119.7, 119.8, 121.51, 121.53, 125.3, 127.3, 127.8, 
131.6, 131.7, 133.7, 135.2, 135.4, 137.0, 139.6, 140.9, 141.1, 142.3, 144.6, 145.0, 149.15, 
149.18, 153.80, 153.84; HRMS m/z 243.10514 (calcd C18H13N, 243.10480). 
OMe
OMe3m + 3n
CN
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(2,3-Dimethoxyfluoren-9-ylidene)acetonitriles (3m + 3n).  These compounds were 
obtained as a orange solid as a 4:1 mixture: 1H NMR (300 MHz, CDCl3) δ 3.97 (s, 12H), 
4.01 (s, 12H), 4.10 (s, 3H), 4.13 (s, 3H), 5.92 (s, 4H), 7.07 (s, 4H), 7.16-7.20 (m, 4H), 7.35-
7.39 (m, 4H), 7.44-7.50 (m, 8H), 7.57-7.63 (m, 2H), 7.74-7.78 (m, 1H), 7.91 (s, 5H), 7.98 (s, 
1H), 8.14 (s, 1H), 8.50 (d, J = 8.4 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 56.3, 56.4, 63.6, 
66.2, 86.6, 103.2, 103.5, 104.8, 105.9, 108.2, 115.5, 118.1, 118.6, 119.23, 119.29, 121.4, 
122.5, 126.7, 127.0, 127.5, 127.7, 129.4, 129.5, 129.7, 131.7, 133.6, 134.1, 136.4, 137.0, 
140.8, 149.4, 150.7, 152.6, 153.7; HRMS m/z 263.09505 (calcd C17H13NO2, 263.09463). 
CO2Et
3o
 
Ethyl (phenanthren-9-yl)acetate (3o).  This compound was obtained as a yellow 
solid: mp 55-57 oC; 1H NMR (400 MHz, CDCl3) δ 1.21 (t, J = 7.1 Hz, 3H), 4.10 (s, 2H), 4.16 
(q, J = 7.1 Hz, 2H), 7.56-7.68 (m, 5H), 7.85 (d, J = 7.5 Hz, 1H), 8.02-8.04 (m, 1H), 8.66 (d, J 
= 8.1 Hz, 1H), 8.72-8.74 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 14.4, 40.0, 61.2, 122.6, 
123.3, 124.6, 126.6, 126.8, 126.9, 127.0, 128.5, 129.0, 129.3, 130.3, 130.8, 131.2, 131.7, 
171.7; HRMS m/z 264.11547 (calcd C18H16O2, 264.11503).  
CO2Et
OMe
OMe
3p
 
Ethyl (6,7-dimethoxyphenanthren-9-yl)acetate (3p).  This compound was obtained 
as a yellow oil: 1H NMR (400 MHz, CDCl3) δ 1.21 (t, J = 7.0 Hz, 3H), 4.05-4.06 (m, 5H), 
4.12-4.18 (m, 5H), 7.44 (s, 1H), 7.50-7.54 (m, 1H), 7.58-7.61 (m, 2H), 7.84 (d, J = 7.6 Hz, 
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1H), 8.04 (s, 1H), 8.50 (d, J = 8.2 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 14.4, 40.7, 56.0, 
56.1, 61.2, 103.9, 105.1, 122.1, 125.6, 125.9, 126.3, 126.4, 127.3, 128.5, 128.6, 129.8, 131.2, 
149.2, 149.4, 171.8; HRMS m/z 324.13656 (calcd C20H20O4, 324.13616). 
CN
3r
 
(Phenanthren-9-yl)acetonitrile (3r).  This compound was obtained as a yellow 
solid: mp 103-105 oC (lit.10b 104-106 oC); 13C NMR (100 MHz, CDCl3) δ 22.4, 117.8, 122.7, 
123.2, 123.7, 124.3, 127.32, 127.39, 127.51, 127.58, 127.6, 128.8, 129.6, 130.5, 130.9, 131.2. 
The 1H NMR spectrum matches the literature data.10b 
CN
3s
 
(9,10-Dihydro-8H-cyclopenta[b]phenanthren-6-yl)acetonitrile (3s).  This 
compound was obtained as a pale yellow solid: mp 134-136 oC; 1H NMR (400 MHz, CDCl3) 
δ 2.19-2.26 (m, 2H), 3.13-3.20 (m, 4H), 7.56-7.66 (m, 2H), 7.72 (s, 1H), 7.81 (s, 1H), 7.87 
(d, J = 7.6 Hz, 1H), 8.60-8.65 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 22.7, 26.2, 33.2, 33.3, 
118.0, 118.2, 118.7, 122.6, 124.3, 126.6, 126.7, 127.2, 128.71, 128.78, 129.9, 130.7, 131.0, 
144.6, 144.8; HRMS m/z 257.12093 (calcd C19H15N, 257.12045). 
CN
Me
Me
3t
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(6,7-Dimethylphenanthren-9-yl)acetonitrile (3t).  This compound was obtained as a 
pale yellow solid: mp 154-156 oC; 1H NMR (400 MHz, CDCl3) δ 2.51 (s, 3H), 2.55 (s, 3H), 
4.15 (s, 2H), 7.56-7.67 (m, 3H), 7.80 (s, 1H), 7.87 (d, J = 7.6 Hz, 1H), 8.50 (s, 1H), 8.63 (d, J 
= 8.2 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 20.6, 20.7, 22.4, 118.0, 122.5, 123.5, 123.9, 
124.0, 126.6, 126.8, 127.2, 128.2, 128.7, 129.2, 130.3, 131.0, 136.7, 136.9; HRMS m/z 
245.12075 (calcd C18H15N, 245.12045). 
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CHAPTER 4. HIGHLY SUBSTITUTED INDOLE LIBRARY SYNTHESIS BY 
PALLADIUM-CATALYZED COUPLING REACTIONS IN SOLUTION AND ON A 
SOLID SUPPORT 
 
Based on a paper to be submitted to the Journal of Combinatorial Chemistry20 
Shilpa A. Worlikar,† Benjamin Neuenswander,‡ Gerald H. Lushington,‡ Richard C. Larock,*,† 
Department of Chemistry, Iowa State University, Ames, IA 50011, and the University of 
Kansas NIH Center of Excellence in Chemical Methodologies and Library Development, 
Lawrence, Kansas 66047 
 
Abstract 
 3-Iodoindoles have been synthesized mainly by the iodocyclization of N,N-dialkyl-o-
(1-alkynyl)anilines, obtained by the Pd/Cu catalyzed coupling of terminal acetylenes with 
N,N-dialkyl-o-iodoanilines.  These 3-iodoindoles undergo palladium-catalyzed Sonogashira 
and Suzuki coupling reactions to yield 1,2,3-trisubstituted indoles.  These reactions have 
been applied to parallel library synthesis utilizing commercially available terminal acetylenes 
and boronic acids.  The aforementioned chemistry has also been carried out on a chlorinated 
Wang resin as a solid support, affording 1,2,3,5-tetrasubstituted indoles after cleavage. A 
diverse 42-member library of highly substituted indoles has been synthesized.  
 
Introduction 
                                                 
* Corresponding author: phone: (515) 294-4660. E-mail: larock@iastate.edu. 
† Iowa State University. 
‡ University of Kansas. 
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 Indoles are very important in medicinal chemistry and the indole moiety is prevalent 
in numerous naturally-occurring and synthetic biologically active compounds.1  It is one of 
the most important nitrogen-containing pharmacophores,2 and is present in various drugs.1b,1g  
Due to the importance of the indole nucleus, many synthetic approaches to this ring system 
have been developed in our research group and reported in the literature for the synthesis of 
substituted indoles.3  Biologically active natural products are a good indicator of lead 
structures that might possess biological activity.  Due to the biological importance of 
compounds containing the indole nuclei, it is quite likely that the libraries of low molecular 
weight indoles will display similar activity and thus serve as valuable tools for drug 
development.  Several methods are known for the synthesis of indoles in solution phase4 and 
on a solid support5 by combinatorial methods, but 3-iodoindoles have not previously been 
examined as key intermediates for indole library synthesis.   
 Yamanaka et al. have reported the coupling of 3-iodoindoles with terminal 
acetylenes, but satisfactory results were obtained only when the N atom of the indole was 
protected with an electron-withdrawing 1-methanesulfonyl group.6  With an electron-
donating group on the N atom of the 3-iodoindole, the C-I bond is electron-rich and this 
appears to limit further functionalization at the 3 position of the indole by palladium-
catalyzed coupling reactions. 
 Previously, in our laboratory, we have synthesized N,N-dialkyl-o-(1-alkynyl)anilines 
(1) by coupling terminal acetylenes with N,N-dialkyl-o-iodoanilines in the presence of a 
Pd/Cu catalyst, which on iodocyclization yield 3-iodoindoles (2) in excellent yields (Scheme 
1).7  We have previously reported individual examples of  Sonogashira8 and Suzuki-Miyaura9 
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cross-coupling reactions, which provide the corresponding 1,2,3-trisubstituted indoles in 
good yields (Scheme 2).6b  We further optimized each of these processes in order to adapt 
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them for library generation.  We have previously also reported individual examples of these 
two coupling reactions on a solid support, followed by cleavage by base.10  The development 
of a solid phase version of this chemistry allows the multistep synthesis of highly substituted 
indoles and eliminates cumbersome purification steps.  We herein report the successful 
synthesis of 1,2,3,5-tetrasubstituted indoles on a solid support by slight modifications of our 
earlier procedure and alternative cleavage reactions (Scheme 3).  
 
Results and Discussion 
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 Our previous work on 3-iodoindole synthesis reported good yields of single 
cyclization products if R2 is a methyl or a phenyl group in the corresponding N,N-dialkyl-o-
(1-alkynyl)anilines (1).  After the iodocyclization step in the former case, the N-atom of the 
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3-iodoindole is protected by a methyl group, and, in the latter case, by a phenyl group.  Our 
desire for a low molecular weight indole library led us to choose methyl as the N-protecting 
group.  Therefore, our choice of R2 was a methyl group in our solution phase library 
synthesis.  3-Iodoindole 2{1} was synthesized as our basic scaffold by using our previous 
cyclization method.7  The 3-iodoindoles 2{2} and 2{3} were similarly synthesized from the 
corresponding N,N-dialkyl-o-(1-alkynyl)anilines 1.  Due to certain limitations in the types of 
R1 and R2 groups that can be employed in our iodocyclization methodology, we synthesized 
the 3-iodoindoles 2{4}11 and 2{5}12 by literature methods, while the 3-iodoindole 2{6} was 
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obtained by treatment of 2{5} with NaBH4.  Accordingly, we choose a subset of various 3-
iodoindoles on the basis of the ease of synthesis from readily available starting materials and 
with different electron-donating and electron-withdrawing functionalities at the 2-position of 
the indoles (Figure 1). 
 
N
Me
I
N
Me
I
N
Me
I
OMe CN
N
I
Me
CHO N
I
H
CHO N
I
H
OH
2{1} 2{2} 2{3}
2{4} 2{5} 2{6}  
Figure 1.  3-Iodoindole sublibrary. 
 
 The terminal alkyne sublibrary was chosen on the basis of commercially available 
acetylenes.  Attempts were made to include heteroatoms in the acetylenes that could impart 
drug-like, hydrogen bond donor and/or acceptor properties to the indoles after Sonogashira 
coupling (Figure 2).  For similar reasons, acetylenes 3{5} and 3{8} were chosen due to the 
increasing popularity of fluorine13 and sulfur14 atoms in drug molecules. 
 The boronic acids for the Suzuki-Miyaura reactions were also chosen on the basis of 
their commercial availability and their ability to provide the requisite diversity and drug-like 
properties to the indole scaffold after subsequent cross-coupling reactions (Figure 3).  For 
instance, the methoxy-containing boronic acids 4{1} and 4{2} were chosen with a view 
towards increasing the polarity of the substituted indole.  The N-heterocyclic boronic acids 
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Figure 2. Terminal acetylene sublibrary. 
 
4{3}, 4{4} and the indolylboronic acid 4{9}, were chosen to increase the drug-like nature of 
the corresponding indoles.  The fluorine-containing acids 4{8} and 4{10} were desirable due 
to the importance of fluorine in medicinal chemistry.  
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Figure 4. Boronic acid sublibrary. 
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 Having chosen these sublibraries, we proceeded to prepare a diverse library of 1,2,3- 
trisubstituted indoles via solution phase chemistry as outlined in Scheme 2 and 1,2,3,5-
tetrasubstituted indoles using a chlorinated Wang resin as the solid support as depicted in 
Scheme 3.  The crude products have been analyzed by LC/MS, followed by purification by 
preparative HPLC or flash chromatography. 
 A summary of the results of the library synthesis is provided in Tables 1-3.  Most of 
the crude products were subjected to preparative HPLC.  Purities in the range of 70-100% 
have been achieved after purification.  Most of the Sonogashira coupling reactions proceeded 
well, except for those run with the terminal alkynes 3{11} and 3{12}.  Suzuki-Miyaura  
 
Table 1. Library Data for Compounds 5{1-29} 
N
Me
N
Me
N
MeOMe CN
N
Me
CHO N
H
CHO N
H
OH
5{1-8} 5{9-13} 5{14}
5{15-20} 5{21-25} 5{26-29}
R R R
R R R
 
 
compound R yielda (%) purityb (%) 
5{1} 4-MeOC6H4 12 97 
5{2} 3,5-dimethoxyphenyl 38 94 
5{3} 4-fluoro-3-methylphenyl 47 99 
5{4} 4-H2NC6H4 27 95 
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Table 1. Continued 
compound R yielda (%) purityb (%) 
5{5} 4-Me2NC6H4 30 79 
5{6} 1-amino-1-cyclohexyl - - 
5{7} 2-hydroxypropyl - - 
5{8} (1-hydroxy-1-methyl)ethyl 13 70 
5{9} C6H5 43 99 
5{10} 3,5-dimethoxyphenyl 34 98 
5{11} 4-Me2NC6H4 59 97 
5{12} 3-thiophenyl 20 93 
5{13} (1-hydroxy-1-methyl)ethyl 33 90 
5{14} C6H5 45 98 
5{15} C6H5 89 100 
5{16} 4-MeOC6H4 90 97 
5{17} 3-MeOC6H4 79 95 
5{18} 3,5-dimethoxyphenyl 94 91 
5{19} 1-methyl-1H-imidazol-5-yl 82 90 
5{20} (1-hydroxy-1-methyl)ethyl 77 95 
5{21} C6H5 52 100 
5{22} 3,5-dimethoxyphenyl 52 90 
5{23} 1-methyl-1H-imidazol-5-yl 36 98 
5{24} 3-thiophenyl 76 93 
5{25} (1-hydroxy-1-methyl)ethyl 43 96 
5{26} 4-MeOC6H4 21 86 
5{27} 3-MeOC6H4 36 92 
5{28} 3,5-dimethoxyphenyl 3 100 
5{29} (1-hydroxy-1-methyl)ethyl 13 95 
a Isolated yield after preparative HPLC.  
b UV purities determined at 214 nm after preparative HPLC. 
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reactions with the boronic acids 4{10} and 4{11} with electron-withdrawing groups failed to 
give the desired coupling products.  The boronic acids  4{3} and 4{8} gave decent yields of 
the coupling products 5{32} and 5{33} and excellent purities when reacted with 3-
iodoindole 2{2}, but failed to give the corresponding trisubstituted indoles when coupled 
with 3-iodoindole 2{3}.  On the solid support, the cleavage by MeMgBr was successful, but 
EtMgBr failed to give the anticipated products.  Out of a total of 51 palladium-catalyzed 
processes attempted, around 80% were successful. 
 
Table 2. Library Data for Compounds 5{30-45} 
 
N
Me
R
N
Me
R
N
Me
R
OMe CN
N
R
Me
CHO N
R
H
CHO N
R
H
OH
5{30} 5{31-37} 5{38-39}
5{40-42} 5{43-44} 5{45}  
 
compound Ar yielda (%) purityb (%) 
5{30} 4-MeOC6H4 23 100 
5{31} 3,4,5-trimethoxyphenyl 79 83 
5{32} 3-fluoro-4-methoxyphenyl 42 100 
5{33} 2-methoxy-5-pyridinyl 50 98 
5{34} benzo[1,3]dioxol-5-yl 39 99 
5{35} 2-methoxy-5-pyrimidinyl 59 99 
5{36} 4-H2NC(O)C6H4 - - 
5{37} 4-EtO2C-3-FC6H3 - - 
5{38} 3-fluoro-4-methoxyphenyl - - 
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Table 2. Continued 
compound Ar yielda (%) purityb (%) 
5{39} 2-methoxy-5-pyridinyl - - 
5{40} 2,3-dihydrobenzo[1,4]dioxin-6-yl 84 89 
5{41} 2-methoxy-5-pyrimidinyl 2 100 
5{42} 6-indolyl 25 94 
5{43} benzo[1,3]dioxol-5-yl 9 100 
5{44} 6-indolyl - - 
5{45} 4-(tetrahydropyran-2-yloxy)phenyl 9 91 
a Isolated yield after preparative HPLC.  
b UV purities determined at 214 nm after preparative HPLC. 
 
Table 3. Library Data for Compounds 5{14-45} 
 
N
Ph
RHO
R2
N
Ph
R
R2 HO
5{46} : R2 = Me
5{47-48} : R2 = Et
5{49-51}
 
compound R yielda (%) purityb (%) 
5{46} C6H5 69c <90d 
5{47} 
O
O
 
-  
5{48} C6H5OMe-p  
-  
5{49} C6H5 60c <90d 
5{50} 
O
O
 
54 91 
5{51} C6H5OMe-p  
64 95 
a Isolated yield after preparative HPLC.  
b UV purities determined at 214 nm after preparative HPLC. 
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c Isolated yield after flash chromatography. 
d Purities determined by H1 NMR spectroscopy after flash chromatography. 
 
 Our goal in synthesizing these low molecular weight heterocycles is for use in high-
throughput screening projects.  Therefore, we carried out an in silico evaluation of these 
library members to determine their agreement with Lipinski’s15 “rule of five” and Veber’s 
rules.16  The SYBYL17 program was used for the calculation of molecular weight, clog P, the 
number of hydrogen bond donors and acceptors, and the number of rotatable bonds for each 
library member (Table 4).  According to these rules a potential drug molecule is more drug-
like and more bioavailable if the clog P value is not more than 5, the molecular weight is less 
than 500, the hydrogen bond acceptors are not more than 10, the hydrogen bond donors are 
not more than 5, and the rotatable bonds in the molecule are not more than 12.  One Lipinski 
violation is allowed for potential drug design.  All of the indole library members are Lipinski 
compliant and no molecule has more than one Lipinski violation.  The only violation that a 
molecule in the library had was clog P, which points towards potential solubility and delivery 
issues.  
 
Table 4.  In silico parameters for gauging oral availability / drug-likeness 
 Mean St. Dev. Range 
Clog P 5.1 1.9 0.6 - 8.0 
Mol. Weight 317 53 227-433 
H-Bond Acceptors 2.0 0.9 0 - 4 
H-Bond Donors 0.8 0.8 0 - 3 
Rotatable Bonds 4.1 1.1 2 - 6 
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Conclusions 
 In conclusion, the synthesis of 4-iodoindoles and subsequent palladium-catalyzed 
Sonogashira and Suzuki-Miyaura cross-coupling reactions with various commercially 
available terminal alkynes and boronic acids have allowed the construction of a 42-member 
library of highly substituted indoles.  The chemistry has been successfully transferred to a 
solid support and diversity has been achieved at the 5-position by different cleavage 
reactions.  The average yield of the library was 46% and the average purity after purification 
was 94%. 
 
Experimental Section 
General  The 1H and 13C NMR spectra were recorded at 300 and 75.5 MHz or 400 
and 100 MHz respectively. Chemical shifts are reported in parts per million (ppm) downfield 
from TMS. Thin layer chromatography was performed using commercially prepared 60-
mesh silica gel plates, and visualization was effected with short wavelength UV light (254 
nm). All reagents were used directly as obtained commercially unless otherwise noted. THF 
and CH2Cl2 were distilled from sodium/benzophenone or CaH2 respectively, under an 
atmosphere of argon prior to use. All glassware and stirring bars were oven dried prior to use.  
HPLC analysis was carried out using an XBridge MS C-18 column (5 μM, 4.6 × 150 
mm) with gradient elution (5% CH3CN to 100% CH3CN) on a Waters Alliance 2795 
Separation Module with a Waters 2996 Photodiode Array UV detector and a 
Waters/Micromass LCT Premier (TOF) detector. Purification was carried out using an 
XBridge MS C-18 column (5 μM, 19 × 150 mm) with a gradient elution (a narrow CH3CN 
gradient was chosen based on the targets retention time from the LCMS analysis of the crude 
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sample) on a Mass Directed Fractionation instrument with a Waters 2767 sample manager, a 
Waters 2525 HPLC pump, a Waters 2487 dual λ absorbance detector, and a 
Waters/Micromass ZQ (quadrupole) detector.  Fractions were triggered using a MS and/or 
UV threshold determined by an LCMS analysis of the crude sample. One of three aqueous 
mobile phases were chosen for both analysis and purification to promote the targets neutral 
state (water, 0.05% formic acid or pH 9.8 1mM HCO2NH4). High resolution mass spectra 
(HRMS) were obtained using a Waters/Micromass LCT Premier (TOF instrument). 
[2-(4-Methoxyphenylethynyl)phenyl]dimethylamine was prepared by literature 
procedure.18 
  
General procedure for the palladium/copper-catalyzed synthesis of N,N-dialkyl-
o-(1-alkynyl)anilines.7  In a 100 ml round bottom flask, PdCl2(PPh3)2 (0.2 mmol, 140.2 mg) 
and CuI (0.1 mmol, 19.0 mg) was added to a solution of N,N-dimethyl-o-iodoaniline (10.0 
mmol, 2.47 g) in Et3N (15 ml).  The flask was then sealed and flushed with Ar.  The reaction 
mixture was stirred for 20 min at room temperature.  A solution of the corresponding alkyne 
(12.0 mmol) in Et3N (10 mL) and DMF (10 ml) was then added dropwise and the reaction 
mixture was allowed to stir at 50 oC till completion of the reaction which was monitored by 
TLC.  After the reaction was over, the resulting solution was diluted with H2O (25 ml) and 
extracted with EtOAc (3 x 20 mL).  The combined EtOAc fractions were dried over 
anhydrous Na2SO4 and concentrated under vacuum to yield the crude product.  The crude 
product was purified by flash chromatography on silica gel using ethyl acetate/hexanes as the 
eluent to afford the desired N,N-dialkyl-o-(1-alkynyl)aniline. 
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N
Me
Me
CN
 
 4-(2-Dimethylaminophenylethynyl)benzonitrile.  Purification by flash 
chromatography (2:1 hexanes/EtOAc) afforded 1.67 g (68%) of the product: 1H NMR 
(CDCl3, 400 MHz) δ 2.99 (s, 6H), 6.88-6.95 (m, 2H), 7.25-7.31 (m, 1H), 7.47-7.49 (dd, J = 
7.6, 1.4 Hz, 1H), 7.58-7.63 (m, 4H); 13C NMR δ 43.72, 93.20, 93.83, 111.21, 113.94, 117.22, 
118.83, 120.65, 128.98, 130.35, 131.81, 132.19, 134.72, 155.23; HRMS Calcd for C17H14N2: 
246.11570.  Found: 246.11610. 
 
General procedure for iodocyclization.  To a solution of N,N-dialkyl-o-(1-
alkynyl)aniline (1.0 mmol) in CH2Cl2 (10 ml), I2 (2 mmol, 508 mg) dissolved in CH2Cl2 (10 
mL) was added gradually.  The reaction mixture was allowed to stir at room temperature for 
the desired time.  The reaction was monitored by TLC.  After the completion of the reaction, 
the excess I2 was removed by washing with satd aq Na2S2O3.  The mixture was then 
extracted by CH2Cl2 (3 x 10 mL).  The combined CH2Cl2 layers were dried over anhydrous 
Na2SO4 and concentrated under vacuum to yield the crude product, which was purified by 
flash chromatography on silica gel using hexanes/ethyl acetate as the eluent to afford the 
desired 3-iodoindole. 
N
I
Me
OMe
2{2}  
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 3-Iodo-2-(4-methoxyphenyl)-1-methyl-1H-indole 2{2}.  Purification by flash 
chromatography (10:1 hexanes/EtOAc) afforded 0.28 g (79%) of the product: 1H NMR 
(CDCl3, 400 MHz) δ 3.65 (s, 3H), 3.87 (s, 3H), 7.01-7.04 (d, J = 8.6 Hz, 2H), 7.20-7.24 (m, 
1H), 7.28-7.29 (d, J = 3.6 Hz, 2H), 7.36-7.39 (d, J = 8.7 Hz, 2H), 7.47-7.49 (d, J = 7.8 Hz, 
1H); 13C NMR δ 32.14, 55.53, 58.95, 109.96, 114.04, 120.79, 121.45, 122.88, 123.92, 
130.47, 132.31, 137.81, 141.81, 160.05; HRMS Calcd for C16H14ONI: 363.01202.  Found: 
363.01253. 
N
I
Me
CN
2{3}  
 4-(3-Iodo-1-methyl-1H-indol-2-yl)benzonitrile 2{3}.  Purification by flash 
chromatography (20:1 hexanes/EtOAc) afforded 0.17 g (48%) of the product: 1H NMR 
(CDCl3, 400 MHz) δ 3.66 (s, 3H), 7.23-7.27 (m, 1H), 7.30-7.36 (m, 2H), 7.49-7.51 (d, J = 7.8 
Hz, 1H), 7.56-7.59 (d, J = 8.2 Hz, 2H), 7.76-7.78 (d, J = 8.3 Hz, 2H); 13C NMR δ 32.40, 
60.39, 110.20, 112.47, 118.65, 121.32, 121.96, 123.93, 130.44, 131.70, 132.32, 136.33, 
138.23, 139.45; HRMS Calcd for C16H11N2I: 357.99670.  Found: 357.99728. 
 
N
H
I
OH
2{6}  
Procedure for the preparation of (3-iodo-1H-indol-2-yl)methanol 2{6}.  A 
modified literature procedure was used.19  In a 100 mL flask to a solution of 3-Iodo-1H-
indole-2-carbaldehyde (3.0 mmol, 0.825 g) in anhydrous THF (20 ml), NaBH4 (6 mmol, ) 
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was added and the reaction mixture was refluxed for 5h.  After the completion of the reaction 
which was monitored by TLC, the reaction mixture was cooled to room temperature and the 
excess NaBH4 was quenched by slow addition of water (20 ml).  THF was removed under 
reduced pressure.  The solid residue was filtered, washed with cold water and dried to afford 
0.60 g (74%) of the desired (3-iodo-1H-indol-2-yl)methanol. : 1H NMR (CDCl3, 400 MHz) δ 
4.82 (s, 2H), 7.15-7.28 (m, 4H), 7.39-7.41 (d, J = 7.5 Hz, 1H), 8.84 (s, 1H); 13C NMR δ 
57.75, 59.18, 111.53, 120.96, 121.03, 123.50, 130.42, 136.15, 137.95; HRMS Calcd for 
C9H9ONI: 273.96507.  Found: 273.96562. 
 
General procedure for Sonogashira coupling in solution phase.  To a 4-dram vial 
was added the appropriate 3-iodoindole (0.2 mmol), PdCl2(PPh3)2 (0.01 mmol, 7.0 mg), CuI 
(0.005 mmol, 1.0 mg), Et3N (1.5 mL), DMF (1.5 mL) and the acetylene (0.3 mmol).  The 
reaction mixture was flushed with argon and stirred for 10 minutes at room temperature.  It 
was then heated to 65 oC until TLC revealed complete conversion of the starting material.  
After the reaction was over, the resulting solution was diluted with H2O (10 ml) and 
extracted with EtOAc (2 x 10 mL).  The combined EtOAc fractions were dried over 
anhydrous Na2SO4 and concentrated under vacuum to yield the crude product.  The residue 
was purified by preparative HPLC.  
 
General procedure for Suzuki-Miyaura cross-coupling in solution phase.  To a 4-
dram vial was added the appropriate 4-iodoindole (0.2 mmol), the aryl boronic acid (0.3 
mmol), Pd(PPh3)4 (0.02 mmol, 23.1 mg) and KOH (1.6 mmol, 89.6 mg) in 5:1 PhCH3:EtOH 
(3.0 mL).  Few drops of water were added to the reaction mixture which was stirred at 90 oC 
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until TLC revealed complete conversion of the starting material.  The reaction mixture was 
cooled, diluted with EtOAc (15 ml) and filtered through celite.  The celite-bed was washed 
with EtOAc.  The filtrate was dried over Na2SO4 and concentrated under reduced pressure.  
The residue was purified by preparative HPLC. 
 
General Procedure for Coupling the Acid to the Polymer-bound 4-
(Benzyloxy)benzyl Chloride Resin.  Chlorinated Wang resin (3.73 g, 0.75 mmol/g) was 
placed in dry DMF (40 mL) for 10 min.  After addition of 3-iodo-4-
[methyl(phenyl)amino]benzoic acid (1.25 g, 1.5 equiv), Cs2CO3 (2.8 g, 3.0 equiv) and KI 
(0.23 g, 0.5 equiv), the mixture was stirred at 80 °C for 2 d.  The reaction mixture was 
allowed to cool to room temperature and the resin was then filtered, washed with water (4 ×), 
DMF (4 ×), methanol (4 ×) and DCM (4 ×), and dried under vacuum overnight.  
 
General procedure for the palladium/copper-catalyzed synthesis of N,N-dialkyl-
o-(1-alkynyl)anilines on solid support.  In a 100 mL round bottom flask were placed the 
acid coupled polymer-bound resin (1.0 g, 0.6 mmol), PdCl2(PPh3)2 (23 mg, 5 mol %) and CuI 
(12.5 mg, 10 mol %). Toluene (13 mL) was added and the reaction mixture was shaken for 5 
min. HNEt2 (13 mL) and the terminal acetylene (5.0 equiv) were added and the mixture was 
shaken at room temperature for 2 d. The polymer was filtered, washed successively with 
DMF (4 ×), MeOH (4 ×) and DCM (4 ×), and dried under vacuum overnight. 
 
General procedure for iodocyclization on solid support.  The appropriate polymer 
bound N,N-dialkyl-o-(1-alkynyl)aniline (800 mg) was placed in DCM (20 mL) for 5 min. I2 
 
118
(0.52 g, 4.0 equiv) was added and the mixture was shaken at room temperature for 24 h. The 
polymer was filtered, washed successively with DMF (4 ×), MeOH (4 ×) and DCM (4 ×), 
and dried under vacuum overnight. 
 
General procedure for Sonogashira cross-coupling on solid support.  In a 100 mL 
round bottom flask were placed the appropriate polymer-bound 3-iodoindole (0.5 g, ~0.3 
mmol), PdCl2(PPh3)2 (12 mg, 5 mol %) and CuI (6.0 mg, 10 mol %). Toluene (7 mL) was 
added and the reaction mixture was shaken for 5 min. HNEt2 (7 mL) and the terminal 
acetylene (5.0 equiv) were added and the mixture was stirred at 65 oC for 2 d. The polymer 
was filtered, washed successively with DMF (4 ×), MeOH (4 ×) and DCM (4 ×), and dried 
under vacuum overnight. 
General procedure for Suzuki-Miyaura cross-coupling on solid support.  In a 100 
mL round bottom flask were placed the appropriate polymer-bound 3-iodoindole (0.5 g, ~0.3 
mmol), Pd(OAc)2 (7.3 mg, 10 mol %), PPh3 (16.7 mg, 20 mol %), CsF (14.2 mg, 4.4 equiv) 
and arylboronic acid (2.5 equiv). DME (15 mL) was added and the reaction mixture was 
heated at 90 °C for 48 h.  The polymer was filtered, washed successively with DMF (4 ×), 
MeOH (4 ×) and DCM (4 ×), and dried under vacuum overnight. 
 
General procedure for cleavage by Lithium Aluminum Hydride.  A solution of 
LAH in THF (1.0 M, 2 mL) was added to a stirred suspension of the appropriate resin-bound 
indole (200 mg) in THF (4 mL) at 0 oC under inert atmosphere.  The mixture was stirred at 0 
oC for 2 h, diluted with THF (2 mL), and quenched with a saturated solution of Na+K+ 
tartrate (8.0 mL). The reaction was warmed to room temperature and stirred vigorously for 2 
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h.  The resulting mixture was filtered and the resin was washed with CH2Cl2.  The biphasic 
filtrate was separated and the aqueous phase was extracted with CH2Cl2.  The combined 
organic layers were washed with brine, dried over Na2SO4 and concentrated under reduced 
pressure.  The residue was purified either by flash chromatography or by preparative HPLC 
to give the final isolated yield of product based upon the loading of resin.  
 
General procedure for cleavage by an alkyl magnesium bromide.  A solution of 
alkyl magnesium bromide in THF (2.0 M, 1 mL) was added to a stirred suspension of the 
appropriate resin bound indole (200 mg) in THF (4 mL) at 0 oC under inert atmosphere.  The 
mixture was gradually warmed to room temperature and stirred for 5 h.  It was then quenched 
with satd solution of ammonium chloride (10 mL).  The resulting mixture was filtered and 
the resin was washed with CH2Cl2.  The biphasic filtrate was separated and the aqueous 
phase was extracted with CH2Cl2.  The combined organic layers were dried over Na2SO4 and 
concentrated under reduced pressure.  The residue was purified either by flash 
chromatography or by preparative HPLC to give the final isolated yield of product based 
upon the loading of resin. 
 
Characterization data for representative library compounds. 
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N
Me
MeO
OMe
5{2}  
3-(3,5-Dimethoxyphenylethynyl)-1-methyl-2-phenyl-1H-indole 5{2}. Yield = 38%; 
1H NMR (CDCl3, 400 MHz) δ 3.76 (s, 3H), 3.78 (s, 6H), 6.38-6.39 (t, J = 2.4 Hz, 1H), 6.59-
6.596 (d, J = 2.4 Hz, 2H), 7.24-7.33 (m, 2H), 7.37-7.39 (m, 1H), 7.43-7.47 (m, 1H), 7.51-
7.55 (m, 2H), 7.66-7.69 (m, 2H), 7.83-7.86 (m, 1H); 13C NMR δ 31.89, 55.59, 84.22, 91.98, 
96.83, 100.91, 109.10, 110.06, 120.27, 121.06, 123.14, 126.06, 128.58, 128.75, 128.94, 
130.49, 130.96, 137.39, 144.27, 160.64. 
 
N
Me
F
Me
5{3}  
3-(4-Fluoro-3-methylphenylethynyl)-1-methyl-2-phenyl-1H-indole 5{3}. Yield = 
47%; 1H NMR (CDCl3, 400 MHz) δ 2.24 (d, J = 2.0 Hz, 3H), 3.75 (s, 3H), 6.89-6.94 (t, J = 
9.6 Hz, 1H), 7.19-7.20 (m, 1H), 7.24-7.27 (m, 2H), 7.29-7.33 (m, 1H), 7.36-7.38 (m, 1H), 
7.43-7.47 (m, 1H), 7.51-7.55 (m, 2H), 7.66-7.68 (m, 2H), 7.81-7.83 (m, 1H); 13C NMR δ 
14.61, 14.64, 31.87, 83.52, 91.01, 96.92, 110.05, 115.12, 115.35, 120.22, 120.39, 120.43, 
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121.00, 123.12, 125.02, 125.20, 128.59, 128.72, 128.97, 130.39, 130.46, 131.03, 134.34, 
134.39, 137.38, 143.92, 159.58, 162.03 (extra peaks due to C-F splitting). 
 
N
Me
OH
Me Me
OMe
5{13}  
4-[2-(4-Methoxyphenyl)-1-methyl-1H-indol-3-yl]-2-methylbut-3-yn-2-ol 5{13}. 
Yield = 33%; 1H NMR (CDCl3, 400 MHz) δ 1.59 (s, 6H), 3.71 (s, 3H), 3.88 (s, 3H), 7.01-
7.04 (m, 2H), 7.18-7.29 (m, 3H), 7.32-7.34 (m, 1H), 7.52-7.55 (m, 2H), 7.69-7.71 (m, 1H); 
13C NMR δ 31.74, 31.93, 55.56, 66.16, 68.69, 95.61, 96.20, 109.86, 113.97, 119.85, 120.83, 
122.76, 123.24, 129.01, 131.64, 137.15, 143.98, 159.94. 
 
N
Me
N
5{14}  
4-(1-Methyl-3-phenylethynyl-1H-indol-2-yl)benzonitrile 5{14}. Yield = 45%; 1H 
NMR (CDCl3, 400 MHz) δ 3.75 (s, 3H), 7.24-7.37 (m, 6H), 7.42-7.44 (m, 2H), 7.80 (s, 4H), 
7.84-7.86 (dt, J = 7.6, 0.8 Hz, 1H); 13C NMR δ 32.11, 83.38, 92.86, 98.73, 110.25, 112.03, 
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118.91, 120.65, 121.48, 124.10, 127.91, 128.56, 128.78, 130.85, 131.34, 132.34, 135.60, 
137.91, 141.32. 
N
CHO
Me
5{15}  
1-Methyl-3-phenylethynyl-1H-indole-2-carbaldehyde 5{15}. Yield = 89%; 1H 
NMR (CDCl3, 400 MHz) δ 4.06 (s, 3H), 7.23-7.26 (m, 1H), 7.34-7.39 (m, 4H), 7.43-7.46 (m, 
1H), 7.57-7.59 (m, 2H), 7.87-7.89 (m, 1H), 10.25 (s, 1H); 13C NMR δ 31.96, 80.48, 97.08, 
110.69, 111.97, 121.82, 122.32, 123.17, 127.72, 127.92, 128.64, 128.71, 131.68, 135.47, 
139.62, 182.44. 
 
N
CHO
Me
5{17}
OMe
 
3-(3-Methoxyphenylethynyl)-1-methyl-1H-indole-2-carbaldehyde 5{17}. Yield = 
79%; 1H NMR (CDCl3, 400 MHz) δ 3.83 (s, 3H), 4.07 (s, 3H), 6.91-6.93 (m, 1H), 7.09-7.10 
(m, 1H), 7.17-7.19 (m, 1H), 7.23-7.30 (m, 3H)(one extra proton due to merger with CDCl3 
peak), 7.35-7.37 (d, J = 6.8 Hz, 1H), 7.44-7.47 (m, 1H), 7.88-7.90 (m, 1H), 10.2 (s, 1H); 13C 
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NMR δ 31.98, 55.50, 80.32, 97.01, 100.93, 110.71, 111.89, 115.34, 116.32, 121.85, 122.34, 
124.27, 127.74, 127.95, 129.73, 135.54, 139.64, 159.54, 182.46. 
N
CHO
Me
5{18}
OMe
MeO
 
3-(3,5-Dimethoxyphenylethynyl)-1-methyl-1H-indole-2-carbaldehyde 5{18}. 
Yield = 94%; 1H NMR (CDCl3, 400 MHz) δ 3.81 (s, 6H), 4.06 (s, 3H), 6.48-6.49 (t, J = 2.0 
Hz, 1H), 6.71-6.73 (m, 2H), 7.23-7.26 (m, 2H)(one extra proton due to merger with CDCl3 
peak), 7.35-7.36 (d, J = 6.8 Hz, 1H), 7.43-7.46 (m, 1H), 7.88-7.89 (d, J = 6.8 Hz, 1H), 10.25 
(s, 1H); 13C NMR δ 31.95, 55.62, 80.08, 97.08, 102.13, 109.34, 110.70, 111.76, 121.84, 
122.31, 124.43, 127.71, 127.93, 135.57, 139.61, 160.74, 182.42. 
 
N
CHO
Me
5{19}
N
N
Me
 
1-Methyl-3-(3-methyl-3H-imidazol-4-ylethynyl)-1H-indole-2-carbaldehyde 
5{19}. Yield = 82%; 1H NMR (CDCl3, 400 MHz) δ 3.77 (s, 3H), 4.06 (s, 3H), 7.25-7.28 (m, 
1H), 7.37-7.41 (m, 2H), 7.45-7.49 (m, 1H), 7.53 (s, 1H), 7.81-7.83 (m, 1H), 10.20 (s, 1H); 
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13C NMR δ 31.96, 32.33, 84.29, 87.55, 110.79, 116.27, 122.03, 127.43, 128.02, 128.57, 
132.11, 134.71, 135.28, 138.73, 139.50, 181.84. 
N
CHO
Me
5{20}
OH
 
3-(3-Hydroxy-3-methylbut-1-ynyl)-1-methyl-1H-indole-2-carbaldehyde 5{20}. 
Yield = 77%; 1H NMR (CDCl3, 400 MHz) δ 1.70 (s, 6H), 3.21 (broad s, 1H), 3.93 (s, 3H), 
7.16-7.19 (m, 1H), 7.22-7.24 (d, J = 6.8 Hz, 1H), 7.36-7.39 (m, 1H), 7.72-7.74 (m, 1H), 
10.08 (s, 1H); 13C NMR δ 31.70, 65.89, 72.93, 98.43, 101.94, 110.52, 111.49, 121.61, 
122.02, 127.55, 127.80, 135.35, 139.35, 182.51. 
 
N
CHO
H
5{21}  
3-Phenylethynyl-1H-indole-2-carbaldehyde 5{21}. Yield = 52%; 1H NMR (CDCl3, 
400 MHz) δ 7.26-7.29 (m, 1H), 7.39-7.48 (m, 5H), 7.61-7.63 (m, 2H), 7.92-7.93 (dd, J = 6.4, 
0.4 Hz, 1H), 9.43 (broad s, 1H), 10.16 (s, 1H); 13C NMR δ 80.19, 96.88, 110.21, 112.90, 
122.10, 122.48, 123.04, 128.39, 128.73, 128.80, 128.95, 131.87, 136.32, 137.17, 181.29. 
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N
CHO
H
5{23}
N
N
Me
 
3-(3-Methyl-3H-imidazol-4-ylethynyl)-1H-indole-2-carbaldehyde 5{23}. Yield = 
36%; 1H NMR (CDCl3, 400 MHz) δ 3.82 (s, 3H), 7.22-7.30 (m, 2H) (one extra proton due to 
merger with CDCl3 peak), 7.45-7.47 (m, 3H), 7.58 (s, 1H), 7.86-7.87 (d, J = 6.4 Hz, 1H), 
9.27 (broad s, 1H), 10.12 (s, 1H); 13C NMR δ 68.20, 84.16, 98.66, 108.16, 112.94, 122.27, 
122.39, 128.52, 128.59, 130.44, 135.17, 136.26, 136.95, 138.95, 180.74. 
 
N
CHO
H
5{25}
OH
 
3-(3-Hydroxy-3-methylbut-1-ynyl)-1H-indole-2-carbaldehyde 5{25}. Yield = 
43%; 1H NMR (CDCl3, 400 MHz) δ 1.71 (s, 6H), 7.41-7.55 (m, 3H), 7.65-7.69 (m, 1H), 
7.79-7.81 (dd, J = 6.4, 0.8 Hz, 1H), 9.29 (broad s, 1H), 10.03 (s, 1H); 13C NMR δ 31.79, 
66.17, 101.44, 108.16, 109.43, 112.80, 122.04, 128.31, 128.68, 132.27, 136.41, 136.96, 
181.21. 
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N
Me
OMe
5{30}  
3-(4-Methoxyphenyl)-1-methyl-2-phenyl-1H-indole 5{30}.  Yield = 23%; 1H NMR 
(CDCl3, 400 MHz) δ 3.67 (s, 3H), 3.79 (s, 3H), 6.81-6.83 (m, 2H), 7.16-7.24 (m, 3H), 7.27-
7.41 (m, 7H), 7.74-7.76 (d, J = 8.0 Hz, 1H); 13C NMR δ 31.37, 55.30, 109.72, 113.96, 
114.94, 119.80, 120.21, 122.33, 127.35, 127.76, 128.12, 128.59, 131.12, 131.43, 132.26, 
137.64, 157.80, 167.48. 
 
N
Me
OMe
OMeF
5{32}  
 
3-(3-Fluoro-4-methoxyphenyl)-2-(4-methoxyphenyl)-1-methyl-1H-indole 5{32}. 
Yield = 42%; 1H NMR (CDCl3, 400 MHz) δ 3.64 (s, 3H), 3.83 (s, 3H), 3.86 (s, 3H), 6.84-
6.93 (m, 3H), 6.99-7.04 (m, 2H), 7.15-7.282 (m, 3H), 7.285-7.30 (m, 1H), 7.37-7.39 (d, J = 
8.0 Hz, 1H), 7.72-7.74 (m, 1H); 13C NMR δ 31.02, 55.46, 56.41, 109.76, 113.44, 113.46, 
113.57, 114.20, 117.39, 117.57, 119.37, 120.40, 122.27, 123.98, 125.61, 125.64, 127.03, 
128.87, 128.94, 132.45, 137.29, 137.80, 145.55, 145.66, 151.15, 153.58, 159.70 (extra peaks 
due to fluorine splitting). 
 
127
N
N
Me
OMe
OMe
5{33}  
2-(4-Methoxyphenyl)-3-(6-methoxypyridin-3-yl)-1-methyl-1H-indole 5{33}. Yield 
= 50%; 1H NMR (CDCl3, 400 MHz) δ 3.66 (s, 3H), 3.83 (s, 3H), 3.93 (s, 3H), 6.66-6.68 (dd, 
J = 8.8, 0.8 Hz, 1H), 6.91-6.93 (m, 2H), 7.16-7.28 (m, 3H), 7.29-7.31 (m, 1H), 7.39-7.41 (d, 
J = 8.0 1H), 7.45-7.47 (dd, J = 8.8, 2.4 Hz, 1H), 7.70-7.72 (d, J = 8.0 1H), 8.17 (dd, J = 2.4, 
0.4 Hz, 1H); 13C NMR δ 31.05, 53.61, 55.47, 109.82, 110.58, 111.17, 114.29, 119.21, 120.50, 
122.37, 123.76, 124.67, 127.10, 132.44, 137.34, 138.10, 140.37, 147.23, 159.77, 162.24. 
 
N
Me
OMe
O
O
5{34}  
3-Benzo[1,3]dioxol-5-yl-2-(4-methoxyphenyl)-1-methyl-1H-indole 5{34}. Yield = 
39%;  1H NMR (CDCl3, 400 MHz) δ 3.64 (s, 3H), 3.84 (s, 3H), 5.92 (s, 2H), 6.75-6.77 (m, 
3H), 6.91-6.93 (d, J = 8.8 Hz, 2H), 7.16-7.24 (m, 4H), 7.27-7.37 (m, 1H), 7.72-7.74 (d, J = 
8.0 Hz, 1H); 13C NMR δ 31.05, 55.46, 100.91, 108.47, 109.68, 110.55, 114.12, 114.64, 
119.57, 120.24, 122.16, 123.39, 124.19, 127.26, 129.45, 132.47, 137.25, 137.58, 145.60, 
147.56, 159.58. 
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N
CHO
H
O
O
5{43}  
3-Benzo[1,3]dioxol-5-yl-1H-indole-2-carbaldehyde 5{43}. Yield = 9%;  1H NMR 
(CDCl3, 400 MHz) δ 6.07 (s, 2H), 6.97-6.98 (d, J = 6.4 Hz, 1H), 7.04-7.09 (m, 2H), 7.18-
7.22 (m, 1H), 7.41-7.48 (m, 2H), 7.79-7.81 (dd, J = 6.4, 0.8 Hz, 1H), 9.14 (broad s, 1H), 9.86 
(s, 1H); 13C NMR δ 101.62, 109.04, 110.77, 112.59, 121.61, 122.45, 124.55, 125.72, 127.01, 
127.99, 129.46, 131.91, 137.30, 147.96, 148.37, 182.80. 
 
N
5{49}
HO
 
(1,2,3-Triphenyl-1H-indol-5-yl)methanol 5{49}. Yield = 60%;  1H NMR (CDCl3, 
400 MHz) δ 4.78 (s, 2H), 7.06-7.39 (m, 18H), 7.77 (s, 1H); 13C NMR δ 66.47, 111.13, 
117.00, 118.68, 122.79, 126.24, 127.43, 127.60, 127.86, 128.09, 128.39, 128.53, 129.30, 
130.41, 131.32, 131.60, 133.89, 134.92, 137.76, 137.79, 138.23. 
 
129
N
5{50}
HO
O
O
 
[3-(2,3-Dihydrobenzo[1,4]dioxin-6-yl)-1,2-diphenyl-1H-indol-5-yl]methanol 
5{50}. Yield = 54%;  1H NMR (CDCl3, 400 MHz) δ 4.24-4.27 (m, 4H), 4.76 (s, 2H), 6.74-
6.80 (m, 2H), 6.941-6.945 (d, J = 1.6 Hz, 1H), 7.07-7.09 (m, 2H), 7.13-7.15 (m, 3H), 7.18-
7.20 (m, 3H), 7.22-7.25 (dd, J = 7.2, 1.6 Hz, 2H) (one extra proton due to merger with CDCl3 
peak, 7.29-7.30 (m, 2H), 7.33-7.36 (m, 2H), 7.75-7.76 (d, J = 0.8 Hz, 1H); 13C NMR δ 64.53, 
66.33, 68.15, 108.10, 110.99, 116.36, 117.31, 118.67, 118.90, 122.72, 123.70, 127.32, 
127.53, 127.90, 128.06, 128.33, 129.25, 131.25, 131.58, 133.79, 137.47, 137.56, 138.22, 
142.14, 143.46. 
 
N
5{51}
HO
OMe
 
[3-(4-Methoxyphenylethynyl)-1,2-diphenyl-1H-indol-5-yl]methanol 5{51}. Yield 
= 64%;  1H NMR (CDCl3, 400 MHz) δ 3.77 (s, 3H), 4.80 (s, 2H), 6.83-6.85 (m, 2H), 7.18-
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7.33 (m, 9H), 7.35-7.38 (m, 2H), 7.42-7.47 (m, 4H), 7.87 (s, 1H); 13C NMR δ 55.44, 66.06, 
82.26, 92.81, 99.18, 108.10, 111.14, 114.06, 116.52, 118.98, 123.39, 127.69, 128.01, 128.03, 
128.07, 129.52, 130.20, 130.83, 132.81, 134.41, 137.43, 138.00, 142.75, 159.19. 
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GENERAL CONCLUSIONS 
In this dissertation, novel and synthetically useful methods involving palladium 
catalysis and electrophilic cyclization have been employed for the synthesis of potential 
medicinally and industrially important carbocycles and heterocycles.  A wide variety of 2H-
benzopyrans, phthalimides, fluorenylidenes, phenanthrenes and indoles have been 
synthesized using these methods. 
 Chapter 1 describes an efficient and mild method to synthesize 2H-benzopyrans by 
iodocyclization of substituted propargylic aryl ethers in good yields.  Successful palladium-
catalyzed Sonogashira and CO insertion reactions have been achieved at the 3-position, 
demonstrating the importance of the iodine handle incorporated in the heterocycle in a 
position not easily achieved previously.  The chemistry is tolerable of a number of functional 
groups. 
 Chapter 2 provides an efficient one step synthesis of phthalimides from readily 
available ortho-halobenzoates and primary amines.  Palladium-catalyzed aminocarbonylation 
has been achieved using one atmosphere of CO without the use of specialized equipment.  
The reaction tolerates a halogen moiety in the heterocycle, which has been further 
successfully subjected to Songashira and Suzuki cross-coupling reactions to achieve decent 
yields of the highly-substituted heterocyles. 
 Chapter 3 describes a successful coupling reaction between two reactive species, 
arynes and organopalladium compounds.  The arynes have been obtained in situ under mild 
reaction conditions from the corresponding o-silylaryl triflates in the presence of CsF.  The 
reaction conditions have been optimized for the palladium-catalyzed aryne annulation of 
ortho-halostyrenes to 9-fluorenylidenes and the methodology extended to ortho-halo 
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allylicbenzenes to afford 9,10-phenanthrenes.  The chemistry is tolerant of a number of 
functional groups. 
 Chapter 4 describes the successful synthesis of a 42-member library of highly 
substituted indoles by the palladium-catalyzed cross-coupling reactions of 3-iodoindoles and 
terminal alkynes or aryl boronic acids.  The palladium-catalyzed reactions on the highly 
electron-rich 3-position of the indole have been achieved in decent yields and good purities, 
both in a solution phase and on a chlorinated Wang resin as the solid support.  Variety has 
been achieved at the 5-position by different cleavage reactions.  The potentially medicinally 
important indole library is totally in compliance with Lipinski rules.  
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